Hypothyroidism (congenital or acquired)

HYPOTHYROIDISM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints E4_CONGEIOD E4_IODGOITRE E4_IODTHYR E4_IODHYPSUB E4_HYTHYSUBS E4_HYTHYPOSTINF E4_ATROTHY E4_MYXOCO E4_HYTHYNAS	68551
6. Filter based on genotype QC (FinnGen only)	66230

Control definitions (FinnGen only)

Control exclude: NEURO_COMORBIDITIES

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	HYPOTHYROIDISM
CONTROL_EXCLUDE	NEURO_COMORBIDITIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_CONGEIOD\|E4_IODGOITRE\|E4_IODTHYR\|E4_IODHYPSUB\|E4_HYTHYSUBS\|E4_HYTHYPOSTINF\|E4_ATROTHY\|E4_MYXOCO\|E4_HYTHYNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypothyroidism (congenital or acquired) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	66230	52885	13345
Unadjusted period prevalence (%)	16.21	18.76	6.11
Median age at first event (years)	52.92	51.09	60.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17651: Matched controls
99687

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

107.9

323.3

282

L03AA13

ATC

pegfilgrastim; parenteral

52.6

322.4

302

A28

ICPC

Limited function/disability NOS

4.5

321.7

999

1304

A04

ICPC

Weakness/tiredness general

2.7

321.3

2258

5152

Z71.8

ICD-10 Finland

Other specified counselling

2.0

320.9

5111

16716

J01DB01

ATC

cefalexin; oral

2.1

319.5

13954

64107

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

6.0

319.2

734

710

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

318.7

6444

22918

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.7

315.0

662

576

F31

ICD-10 Finland

Bipolar affective disorder

154.3

314.9

269

M04AA01

ATC

allopurinol; systemic

5.2

313.9

842

958

N02BF02

ATC

pregabalin; oral

5.9

312.3

739

738

I47.1

ICD-10 Finland

Supraventricular tachycardia

22.3

311.6

349

I20.99

ICD-10 Finland

Angina pectoris, unspecified

88.0

311.6

276

F99

ICD-10 Finland

Mental disorder, not otherwise specified

34.0

311.5

314

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

310.0

6313

22455

SPAT1097

SPAT

Recording of ECG

3.5

309.7

1342

2276

R42

ICD-10 Finland

Dizziness and giddiness

2.5

308.8

2525

6218

A02BC01

ATC

omeprazole; systemic

2.2

308.4

3378

9508

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.9

307.8

1167

1794

IGY99

NOMESCO Finland

Other psychiatric treatment contact

45.1

307.7

398

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

79.4

307.7

439

A06AD11

ATC

lactulose; oral

4.5

307.7

1207

1593

XCK10

NOMESCO Finland

Photography of fundus of eye

5.5

307.7

906

976

C03CA01

ATC

furosemide; systemic

13.0

307.7

2005

975

F40.1

ICD-10 Finland

Social phobias

16.1

307.7

479

172

N03AX09

ATC

lamotrigine; oral

21.4

307.7

1151

324

B01AC04

ATC

clopidogrel; oral

16.3

307.7

848

308

SPAT1249

SPAT

Treatment-related counselling outside office

2.1

307.7

6578

22289

T90

ICPC

Diabetes non-insulin dependent

32.6

307.7

2353

468

A10BJ02

ATC

liraglutide; parenteral

72.4

307.7

327

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

74.4

307.7

512

T89

ICPC

Diabetes insulin dependent

323.4

307.7

871

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.3

307.7

2108

1607

N06AB10

ATC

escitalopram; oral

15.6

307.7

4140

1922

C07AB02

ATC

metoprolol; systemic

5.7

307.7

1554

1663

SPAT1262

SPAT

Handing over of treatment supplies

9.5

307.7

2166

1446

N05BA12

ATC

alprazolam; oral

8.0

307.7

1221

922

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

563.0

307.7

579

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

16.4

307.7

897

324

F41.1

ICD-10 Finland

Generalized anxiety disorder

10.7

307.7

1082

606

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

307.7

3613

9589

XX3DW

NOMESCO Finland

Time consuming IT work

6.4

307.7

925

855

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.0

307.7

1261

1863

N06AB03

ATC

fluoxetine; oral

20.8

307.7

1901

574

N06AX12

ATC

bupropion; oral

33.0

307.7

1770

336

N05AH03

ATC

olanzapine; systemic

154.1

307.7

1172

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

5.8

307.7

2093

2259

ZY010

NOMESCO Finland

Hospital outpatient

12.3

307.7

1013

491

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

6.9

307.7

724

611

A10BK01

ATC

dapagliflozin; oral

238.7

307.7

612

N03AG01

ATC

valproic acid; systemic, rectal

10.9

307.7

1061

584

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

77.2

307.7

309

C09AA02

ATC

enalapril; systemic

4.5

307.7

1386

1869

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

9.7

307.7

524

314

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

89.9

307.7

435

A10AB01

ATC

insulin (human); parenteral

473.9

307.7

725

A10BJ06

ATC

semaglutide; parenteral

+∞

307.7

595

I25.1

ICD-10 Finland

Atherosclerotic heart disease

98.7

307.7

1114

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

175.2

307.7

424

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.2

307.7

1872

3578

UJF32

NOMESCO Finland

Coloscopy

2.9

307.7

2732

5898

A10BH01

ATC

sitagliptin; oral

544.8

307.7

740

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

16.1

307.7

709

259

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

607.5

307.7

623

N03AX12

ATC

[U] gabapentin; oral

3.9

307.7

2050

3267

N06AB05

ATC

paroxetine; oral

22.6

307.7

926

244

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

307.7

2597

5667

N05AX08

ATC

risperidone; systemic

28.0

307.7

1085

233

103

Kela drug reimbursment

Diabetes, insulin-treated

7008.1

307.7

3096

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

307.7

415

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

307.7

3474

8699

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

81.3

307.7

544

N06AX21

ATC

duloxetine; oral

19.4

307.7

2006

653

WX402

NOMESCO Finland

General anaesthesia

2.6

307.7

3096

7497

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.6

307.7

3561

6480

C01DA14

ATC

isosorbide mononitrate; oral

39.9

307.7

574

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.1

307.7

787

648

E03

ICD-10 Finland

Other hypothyroidism

291.5

307.7

3648

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

34.0

307.7

1872

347

P99

ICPC

Psychological disorders other

14.8

307.7

564

222

N03AX16

ATC

[U] pregabalin

4.0

307.7

3004

4854

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.5

307.7

1140

1233

F32

ICD-10 Finland

Depressive episode

11.6

307.7

991

507

Z01.8

ICD-10 Finland

Other specified special examinations

2.6

307.7

3279

8002

N06AA09

ATC

amitriptyline; systemic

7.7

307.7

940

722

E03.89

ICD-10 Finland

Other specified hypothyroidism

304.5

307.7

2008

N06AG02

ATC

moclobemide; oral

29.9

307.7

444

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

76.2

307.7

331

F29

ICD-10 Finland

Unspecified nonorganic psychosis

495.5

307.7

594

A10AB04

ATC

insulin lispro; parenteral

157.0

307.7

643

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

101.2

307.7

334

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2419.5

307.7

424

104

Kela drug reimbursment

Thyroid insufficiency

7788.8

307.7

3374

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.5

307.7

1568

2700

R51.80

ICD-10 Finland

Headache

2.6

307.7

2728

6602

N06AX03

ATC

mianserin; oral

31.1

307.7

519

A10AE04

ATC

insulin glargine; parenteral

125.1

307.7

1332

N02AA05

ATC

oxycodone; systemic

6.1

307.7

1348

1328

I10

ICD-10 Finland

Essential (primary) hypertension

3.4

307.7

5712

12157

N06AX11

ATC

mirtazapine; oral

6.6

307.7

5447

6300

WZC30

NOMESCO Finland

Teaching

4.1

307.7

1884

2829

H03BB01

ATC

carbimazole; oral

16.1

307.7

1515

579

PHD99

NOMESCO Finland

Resection of other vein

2342.5

307.7

411

N05BE01

ATC

buspirone; oral

42.2

307.7

416

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

50.0

307.7

313

I50.9

ICD-10 Finland

Heart failure, unspecified

163.1

307.7

505

N05CF02

ATC

zolpidem; oral

3.6

307.7

2494

4321

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

96.7

307.7

1490

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

10.3

307.7

661

376

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

10.5

307.7

1418

822

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

359.8

307.7

1673

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

24.7

307.7

373

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

72.8

307.7

304

Z2446

NOMESCO Finland

Social worker

7.2

307.7

918

753

P01

ICPC

Feeling anxious/nervous/tense

3.3

307.7

2733

5220

A10AA02, ,

ATC

3051.0

307.7

530

C08CA01

ATC

amlodipine; oral

3.8

307.7

3207

5447

T86

ICPC

Hypothyroidism/myxoedema

198.0

307.7

2317

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

566

N06AX26

ATC

vortioxetine; oral

41.4

307.7

1481

220

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

83.7

307.7

874

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

6.7

307.7

2208

2091

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

120.9

307.7

699

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

16.3

307.7

449

159

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

21.4

307.7

1060

297

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

98.6

307.7

292

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

60.6

307.7

2152

228

H03AA01

ATC

levothyroxine sodium; systemic

13102.0

307.7

17470

729

ZYC01

NOMESCO Finland

Remote contact by phone

5.8

307.7

877

891

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

8.9

307.7

1455

996

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

9.3

307.7

593

370

P29

ICPC

Psychological sympt/compl other

4.4

307.7

1403

1900

I48

ICD-10 Finland

Atrial fibrillation and flutter

97.5

307.7

917

Z2445

NOMESCO Finland

Psychologist

11.7

307.7

733

368

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

+∞

307.7

725

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

307.7

565

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

531.0

307.7

8317

167

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

6.9

307.7

707

597

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.8

307.7

2416

5412

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

1494

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

691

F51.0

ICD-10 Finland

Nonorganic insomnia

3.0

307.7

2796

5929

G47.3

ICD-10 Finland

Sleep apnoea

3.6

307.7

3440

6282

N05BA01

ATC

diazepam; systemic, rectal

5.7

307.7

1650

1781

BAA60

NOMESCO Finland

Total thyroidectomy

354.7

307.7

1389

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

83.1

307.7

318

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

50.9

307.7

345

N02AX02

ATC

tramadol; systemic, rectal

2.5

307.7

5467

15139

C07AA05

ATC

propranolol; systemic

4.4

307.7

3879

6011

ZXE20

NOMESCO Finland

More than three and less than five hours

4.0

307.7

1341

1988

XF404

NOMESCO Finland

Ambulatory ECG

9.1

307.7

651

417

F41.09

ICD-10 Finland

UNS Panic Syndrome

14.7

307.7

483

190

AA1AD

NOMESCO Finland

CT of head and brain

4.0

307.7

2694

4333

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

648

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

112.3

307.7

521

H02AB02

ATC

dexamethasone; systemic

16.4

307.7

897

325

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

461.3

307.7

1074

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

36.3

307.7

656

106

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

7.3

307.7

2572

2265

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

307.7

6063

19330

N05AB03

ATC

perphenazine; systemic, rectal

71.3

307.7

455

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.8

307.7

5572

10692

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.5

307.7

1979

3468

M79.6

ICD-10 Finland

Pain in limb

2.1

307.7

6205

20690

P74

ICPC

Anxiety disorder/anxiety state

8.1

307.7

825

602

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.1

307.7

792

766

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

4.9

307.7

1003

1201

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

71.3

307.7

310

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

307.7

1720

3186

F31.8

ICD-10 Finland

Other bipolar affective disorders

184.6

307.7

446

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

11.4

307.7

903

471

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

110.2

307.7

419

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.8

307.7

1120

1387

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

10.1

307.7

2195

1380

C08CA13

ATC

lercanidipine; oral

4.8

307.7

1007

1243

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

49.1

307.7

646

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

47.3

307.7

513

F33

ICD-10 Finland

Recurrent depressive disorder

34.3

307.7

444

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

7.3

307.7

783

634

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

307.7

3094

6614

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

552.1

307.7

476

OAB50, ,

SPAT

10.1

307.7

643

371

E10

ICD-10 Finland

Type 1 diabetes mellitus

826.8

307.7

425

B01AB05

ATC

enoxaparin; parenteral

2.9

307.7

3441

7684

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

8.0

307.7

630

461

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

9203

34372

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

8.1

307.7

795

577

N06BA04

ATC

methylphenidate; oral

7.6

307.7

678

521

C10AA05

ATC

atorvastatin; oral

3.5

307.7

3797

7303

T36

ICD-10 Finland

Poisoning by systemic antibiotics

22.6

307.7

801

209

JN4AD

NOMESCO Finland

Body CT examination

8.0

307.7

712

520

N06AA12

ATC

doxepin; systemic

16.4

307.7

443

156

N06AX05

ATC

trazodone; oral

58.5

307.7

395

JN4BD

NOMESCO Finland

Extensive body CT

8.0

307.7

758

554

C09AA05

ATC

ramipril; oral

5.7

307.7

1738

1865

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

573

P03

ICPC

Feeling depressed

5.4

307.7

2080

2413

F32.9

ICD-10 Finland

Depressive episode, unspecified

20.7

307.7

2749

881

IGY02

NOMESCO Finland

Psychiatric monitoring contact

37.4

307.7

534

A02BC02

ATC

pantoprazole; systemic

2.8

307.7

10037

31996

F34.1

ICD-10 Finland

Dysthymia

53.2

307.7

697

N05CF01

ATC

zopiclone; oral

4.7

307.7

4073

6008

N06AX22

ATC

agomelatine; oral

72.9

307.7

465

R5140

NOMESCO Finland

Monitoring the use of the aid

3.8

307.7

1354

2146

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.6

307.7

2654

6379

C07AB07

ATC

bisoprolol; oral

6.7

307.7

5098

5693

H02AB06

ATC

prednisolone; systemic

2.1

307.7

6746

22427

H02AB09

ATC

hydrocortisone; systemic

15.1

307.7

636

246

P76

ICPC

Depressive disorder

16.1

307.7

1367

518

A03FA01

ATC

metoclopramide; systemic, rectal

3.9

307.7

2702

4393

B01AF02

ATC

apixaban; oral

21.5

307.7

571

155

N05BA04

ATC

oxazepam; oral

7.2

307.7

4125

4041

N05BA06

ATC

lorazepam; systemic, sublingual

28.1

307.7

560

116

N06AB04

ATC

citalopram; systemic

18.8

307.7

3240

1178

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

567.5

307.7

677

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

8.9

307.7

1398

957

N06AB06

ATC

sertraline; oral

26.3

307.7

2203

537

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

3.9

307.7

1454

2245

P06

ICPC

Sleep disturbance

3.3

307.7

1940

3634

A02BC05

ATC

esomeprazole; systemic

2.2

307.7

5599

17524

A04AA02

ATC

granisetron; systemic, transdermal

78.7

307.7

435

SPAT1240

SPAT

Therapeutic discussion

4.2

307.7

2226

3282

N05AA02

ATC

levomepromazine; systemic

87.7

307.7

615

B01AA03

ATC

warfarin; systemic

31.0

307.7

946

182

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

63.4

307.7

374

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

17.3

307.7

411

137

A10AE05

ATC

insulin detemir; parenteral

668.3

307.7

899

A10AC01

ATC

insulin (human); parenteral

23.9

307.7

1182

298

R06.0

ICD-10 Finland

Dyspnoea

3.3

307.7

3259

6378

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

9.6

307.7

594

362

A10AE06

ATC

insulin degludec; parenteral

+∞

307.7

613

N05AF03

ATC

chlorprothixene; systemic

265.9

307.7

415

C10AX09

ATC

ezetimibe; oral

6.0

307.7

1379

1393

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

8.1

307.7

1020

750

A06AC01

ATC

ispaghula (psylla seeds); oral

2.8

307.7

3137

7240

F61.0

ICD-10 Finland

Mixed personality disorders

135.2

307.7

352

Z3231

NOMESCO Finland

Registered nurse

2.9

307.7

3564

8094

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

683.1

307.7

1026

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

12.4

307.7

665

313

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.9

307.7

3903

6784

A10AB05

ATC

insulin aspart; parenteral

188.7

307.7

1272

C10AA07

ATC

rosuvastatin; oral

2.6

307.7

3398

8243

N05AX12

ATC

aripiprazole; systemic

329.0

307.7

990

N05CD07

ATC

temazepam; oral

10.3

307.7

908

523

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

498.3

307.7

920

F32.1

ICD-10 Finland

Moderate depressive episode

10.8

307.7

1178

655

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

29.8

307.7

621

122

N05AN01

ATC

lithium; oral

204.2

307.7

594

A10AA01, ,

ATC

3009.0

307.7

523

AN1

Coronary angiography

118.0

307.7

547

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

14.7

307.7

479

189

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

307.7

1288

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

307.7

447

N02BE01

ATC

paracetamol; systemic, rectal

2.8

307.7

14614

62961

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

102.5

307.7

425

F90.0

ICD-10 Finland

Disturbance of activity and attention

7.3

307.7

751

606

XF400

NOMESCO Finland

ECG with 12 standard connections

4.5

307.7

1398

1886

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

134.5

307.7

464

E66.01

ICD-10 Finland

Obesity due to excess calories

5.3

307.7

1930

2269

E66.8

ICD-10 Finland

Other obesity

7.3

307.7

1101

895

TPH07

NOMESCO Finland

Cathetrisation of artery

6.5

307.7

920

841

A10BA02

ATC

metformin; oral

28.7

307.7

3115

738

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.1

307.7

1034

1011

WZC00

NOMESCO Finland

Treatment plan or consultation

2.2

307.7

5531

17347

205

Kela drug reimbursment

Chronic hypertension

+∞

307.7

1581

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

137.5

307.7

1266

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

16.3

307.7

1224

455

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

5.9

307.7

766

757

207

Kela drug reimbursment

Chronic arrhythmias

342.0

307.7

642

N03AE01

ATC

clonazepam; systemic

8.0

307.7

693

507

A10BK03

ATC

empagliflozin; oral

531.2

307.7

893

B03BA03

ATC

hydroxocobalamin; parenteral

10.1

307.7

514

296

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

7.9

307.7

983

743

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

130.2

307.7

793

N05AH04

ATC

quetiapine; oral

15.8

307.7

3586

1588

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

8.4

307.7

683

477

ZXE10

NOMESCO Finland

More than one and less than three hours

2.5

307.7

4556

12213

T82

ICPC

Obesity

6.8

307.7

815

708

N06AX16

ATC

venlafaxine; oral

52.1

307.7

2954

383

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

13.4

307.7

514

223

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

79.0

307.7

450

E66.00

ICD-10 Finland

Metabolic syndrome

8.8

307.7

753

500

115

Kela drug reimbursment

Breast cancer

+∞

307.7

480

R53

ICD-10 Finland

Malaise and fatigue

3.0

307.7

4016

8887

215

Kela drug reimbursment

Diabetes, non-insulin-treated

16384.0

307.7

3043

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

11.2

307.7

768

402

C03DA01

ATC

spironolactone; oral

7.5

307.7

953

756

D64.9

ICD-10 Finland

Anaemia, unspecified

10.3

307.7

746

427

EP1AE

NOMESCO Finland

Neck ultrasound examination

8.0

307.7

1171

874

E11

ICD-10 Finland

Type 2 diabetes mellitus

26.4

307.7

1325

305

PJA12

NOMESCO Finland

Sentinel node biopsy

21.1

307.7

459

126

C10AA01

ATC

simvastatin; oral

3.6

307.7

3076

5483

XF402

NOMESCO Finland

ECG with work load test

7.0

307.7

778

648

A11CC03

ATC

alfacalcidol; systemic

44.8

307.7

358

H04AA01

ATC

glucagon; nasal, parenteral

621.6

307.7

637

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

164.7

307.7

399

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

306.4

3751

11055

E66.9

ICD-10 Finland

Obesity, unspecified

6.4

304.9

663

601

C09CA06

ATC

candesartan; oral

2.4

303.5

2869

7562

C03AA03

ATC

hydrochlorothiazide; oral

8.6

303.5

529

357

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

95.7

303.5

267

S18

ICPC

Laceration/cut

1.9

302.9

5641

19428

WF002

NOMESCO Finland

Radical radiotherapy

21.8

302.4

341

C09CA01

ATC

losartan; oral

2.7

301.7

2164

4982

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

21.4

301.5

342

SPAT1310

SPAT

Counselling related to known health issue

2.0

301.1

4734

15347

SPAT1263

SPAT

Sampling

1.9

300.7

6591

23963

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.8

300.7

1157

1798

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

63.1

300.4

275

L28

ICPC

Limited function/disability (L)

3.2

298.0

1473

2728

R4110

NOMESCO Finland

Physiotherapy

2.3

297.5

2989

8091

TFP20

NOMESCO Finland

Cardiodefibrillation

531.7

296.4

369

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

295.9

358

M79.7

ICD-10 Finland

Fibromyalgia

8.3

294.8

524

364

ZX120

NOMESCO Finland

Intravenous

4.3

294.1

968

1327

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

1067.3

292.0

359

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

291.7

12216

54246

F43.1

ICD-10 Finland

Post-traumatic stress disorder

7.9

291.6

539

396

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

4.9

291.5

828

995

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.7

290.5

1180

1908

F41.00

ICD-10 Finland

Moderate panic disorder

65.8

289.8

264

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

2000.8

289.2

353

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.0

288.7

807

955

WX872

NOMESCO Finland

Intensive care

14.8

287.8

374

146

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

53.0

286.4

268

J01AA02

ATC

doxycycline; systemic

1.8

285.7

11613

50893

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

285.4

4375

14009

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

+∞

285.1

345

E06.3

ICD-10 Finland

Autoimmune thyroiditis

23.2

284.6

315

R02

ICPC

Shortness of breath/dyspnoea

3.1

284.2

1527

2978

A04AA55

ATC

palonosetron, combinations; systemic

57.8

283.2

262

A04AA01

ATC

ondansetron; systemic, rectal

5.1

283.0

772

892

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

282.5

2463

6237

SPAT1301

SPAT

No procedures

2.0

280.3

4308

13793

SPAT1260

SPAT

Consultation of another employee

2.4

278.9

2403

6048

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

79.2

278.5

249

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

11.9

278.2

400

194

M54.5

ICD-10 Finland

Low back pain

1.9

278.2

5563

19507

A02BC03

ATC

lansoprazole; oral

2.2

277.7

3160

8998

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

19.2

275.8

324

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

274.3

332

F39

ICD-10 Finland

Unspecified mood [affective] disorder

22.5

274.1

306

G44.2

ICD-10 Finland

Tension-type headache

2.5

273.9

2215

5404

ZXE00

NOMESCO Finland

One hour or less

1.9

273.0

5457

19108

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

273.0

4652

15431

N07BB01

ATC

disulfiram; oral

7.4

272.5

526

410

WX892

NOMESCO Finland

Monitored bed care

5.8

271.1

645

647

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

30.8

270.9

279

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.1

270.7

1404

2676

Z3226

NOMESCO Finland

Physiotherapist

2.6

267.9

2052

4870

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

267.3

6770

25516

L17

ICPC

Foot/toe symptom/complaint

2.1

267.1

3709

11408

N06AB08

ATC

fluvoxamine; oral

30.3

266.2

275

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

1836.7

266.0

325

C08CA02

ATC

felodipine; oral

7.4

264.2

512

401

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

263.6

2521

6646

P01AB01

ATC

metronidazole; oral, rectal

1.8

262.3

5834

21087

K78

ICPC

Atrial fibrillation/flutter

44.9

261.8

251

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

260.8

4180

13535

C02AC05

ATC

moxonidine; oral

23.3

260.5

288

101

Kela drug reimbursment

Anterior pituitary hypofunction

20.4

258.8

298

E66

ICD-10 Finland

Obesity

4.0

256.7

919

1347

R50.9

ICD-10 Finland

Fever, unspecified

2.5

255.9

2040

4932

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

36.4

255.4

254

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

254.6

2270

5790

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

254.5

4589

15459

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

10.1

254.1

400

229

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

13.4

253.2

343

147

F60.9

ICD-10 Finland

Personality disorder, unspecified

54.0

252.9

236

N05AH02

ATC

clozapine; systemic

601.5

252.8

314

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.5

251.8

778

1008

E23.00

ICD-10 Finland

Panhypopituitarism

104.4

250.5

219

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

250.3

5049

17633

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

1725.6

250.3

306

ZY000

NOMESCO Finland

Hospital inpatient

90.3

250.0

221

J02AC01

ATC

fluconazole; systemic

1.8

249.4

6414

24151

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1708.1

247.8

303

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

300.3

247.6

314

L03

ICPC

Low back symptom/complaint

1.9

247.6

4144

13588

I49.3

ICD-10 Finland

Ventricular premature depolarization

5.8

247.3

588

589

N05AD01

ATC

haloperidol; systemic

22.9

245.0

272

N02BF01

ATC

gabapentin; oral

3.8

244.6

951

1485

R11

ICD-10 Finland

Nausea and vomiting

3.2

244.5

1193

2183

M03BX02

ATC

tizanidine; oral

1.7

244.1

9993

42898

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

243.8

1171

2121

177

Kela drug reimbursment

Insulin glargine 300 U / ml

1667.3

242.0

296

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

12.5

241.9

339

156

L03AA02

ATC

filgrastim; parenteral

69.6

241.8

219

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

+∞

241.1

292

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.7

240.0

1618

3583

SPAT1234

SPAT

Support of social functional capacity

8.4

239.7

424

292

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

5.2

239.6

635

712

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

92.8

239.2

211

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.4

238.1

1082

1888

R4190

NOMESCO Finland

Nutritional therapy

6.3

238.0

524

481

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

7.0

237.0

480

398

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

236.1

286

201

Kela drug reimbursment

Chronic cardiac insufficiency

44.6

235.5

226

SPAT1243

SPAT

Psychiatric/psychological examination

6.3

234.6

516

473

Z51.5

ICD-10 Finland

Palliative care

14.9

233.9

302

116

A10BH05

ATC

linagliptin; oral

1609.0

233.8

286

N04AA02

ATC

biperiden; systemic

39.5

232.8

228

XA800

NOMESCO Finland

Neuropsychological investigation

5.9

231.6

539

527

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.0

231.1

815

1179

SPAT1307

SPAT

Psychosocial counselling and guidance

2.9

229.8

1320

2669

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

35.4

229.1

229

WF003

NOMESCO Finland

Adjuvant radiotherapy

51.2

228.7

215

SPAT1153

SPAT

Removal of sutures

2.0

228.1

3522

11184

HA1AA

NOMESCO Finland

X-ray mammography

5.4

228.0

582

628

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.4

227.6

717

944

PHD76

NOMESCO Finland

Resection of long saphenous vein

812.9

227.5

281

A10BB12

ATC

glimepiride; oral

541.0

227.3

283

J01MA12

ATC

levofloxacin; systemic

2.5

224.9

1811

4386

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.0

224.1

1205

2341

M25.5

ICD-10 Finland

Pain in joint

1.8

222.7

4881

17378

H3600, E103,

ICD-10 Finland

+∞

221.2

268

F32.8

ICD-10 Finland

Other depressive episodes

18.5

220.5

262

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

24.9

220.3

239

N06AA06

ATC

trimipramine; systemic

17.9

220.1

265

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

267.1

219.7

280

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1510.0

219.7

269

A10BD07

ATC

metformin and sitagliptin; systemic

781.0

219.3

271

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

108.5

217.9

190

L02BA01

ATC

tamoxifen; oral

23.6

217.1

239

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

11.9

215.7

310

150

C07AG02

ATC

carvedilol; oral

12.2

215.6

305

143

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.9

215.1

500

488

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

19.4

214.7

251

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

83.9

214.7

191

Z2221

NOMESCO Finland

Medical doctor

1.9

214.0

3562

11578

SPAT1252

SPAT

Overall medication plan or its review

5.4

213.9

546

589

J01FF01

ATC

clindamycin; systemic

1.9

213.7

3582

11671

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

212.1

9079

38813

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

212.1

2419

6829

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

72.3

210.6

190

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

210.5

3487

11309

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

209.6

254

HAC20

NOMESCO Finland

Total mastectomy

42.7

209.1

202

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

42.5

207.8

201

ZXA10

NOMESCO Finland

Bilateral

2.3

207.2

1959

5103

B81

ICPC

Anaemia vit B12/folate deficiency

10.8

206.8

313

167

Angiography of the heart and coronary arteries

60.3

206.4

190

SPAT1229

SPAT

Assessment of need for aid

4.8

206.0

589

710

ZXD05

NOMESCO Finland

Urgent procedure

1.8

205.4

4205

14597

SPAT1216

SPAT

Assessment of functional ability

2.8

204.6

1270

2680

R60.0

ICD-10 Finland

Localized oedema

3.1

204.0

1087

2097

WX002

NOMESCO Finland

Sedation and analgesia

2.3

203.6

1866

4791

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

202.4

5053

18602

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

202.4

3020

9429

R00.2

ICD-10 Finland

Palpitations

3.0

202.1

1110

2181

A02BA02

ATC

ranitidine; systemic

2.4

202.0

1717

4257

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.7

200.8

790

1242

N04BC05

ATC

pramipexole; oral

3.9

200.7

730

1081

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

11.5

200.5

292

145

M79.0

ICD-10 Finland

Rheumatism, unspecified

7.7

200.3

375

280

I20.09

ICD-10 Finland

Unstable angina

243.7

200.1

256

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1370.7

199.9

245

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

199.2

1830

4701

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

199.1

1616

3918

ZXE30

NOMESCO Finland

More than five and less than seven hours

6.4

198.4

431

389

TK800

NOMESCO Finland

Hemodialysis

39.6

198.1

194

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

61.1

198.1

182

R06AE07

ATC

cetirizine; oral

1.6

196.3

7208

29410

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

195.4

3903

13414

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

14.5

194.9

255

101

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

+∞

194.7

236

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

10.7

194.5

295

158

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

194.0

4351

15487

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

+∞

193.9

235

TPX10

NOMESCO Finland

Implantation of vascular injection port

13.7

193.8

260

109

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

193.2

2420

7071

C09BA02

ATC

enalapril and diuretics; systemic

6.8

193.1

397

335

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

23.6

191.8

211

J01MA02

ATC

ciprofloxacin; systemic

1.8

191.4

4492

16195

J01FA06

ATC

roxithromycin; oral

1.7

188.9

5348

20317

P72

ICPC

Schizophrenia

274.1

188.5

240

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

31.5

188.4

193

A01

ICPC

Pain general/multiple sites

3.1

187.9

990

1895

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

14.3

187.8

247

E0000UV, ,

ATC

1.7

187.6

6406

25567

H36.00

ICD-10 Finland

Diabetic background retinopathy

446.0

186.9

234

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

19.7

186.5

217

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

186.4

4309

15446

I25.2

ICD-10 Finland

Old myocardial infarction

+∞

185.6

225

SPAT1312

SPAT

General health counselling

1.7

184.8

5147

19440

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.8

184.6

1165

2477

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

267.2

183.6

234

L01BC06

ATC

capecitabine; oral

92.3

183.5

162

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

183.2

8574

36947

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.6

182.9

1347

3108

C01AA05

ATC

digoxin; systemic

26.0

182.9

196

K80

ICPC

Cardiac arrhythmia NOS

3.7

182.7

721

1135

R01AD09

ATC

mometasone; nasal

1.6

182.4

7590

31772

K59.09

ICD-10 Finland

Constipation, unspecified

4.3

182.0

593

802

TFP34

NOMESCO Finland

Electrophysiological investigation

264.8

182.0

232

F33.8

ICD-10 Finland

Other recurrent depressive disorders

71.9

181.7

164

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

181.0

2330

6867

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

53.5

180.9

169

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

+∞

180.7

219

A46

ICD-10 Finland

Erysipelas

2.6

179.8

1253

2809

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

179.8

218

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

179.6

1157

2487

F41.8

ICD-10 Finland

Other specified anxiety disorders

4.7

179.5

531

660

M01AE02

ATC

naproxen; oral, rectal

1.6

179.2

9193

40415

OAB93, ,

SPAT

2.8

178.8

1089

2269

A10AD01

ATC

insulin (human); parenteral

426.6

178.7

224

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

178.7

1724

4516

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

9.8

178.1

284

166

ZXA00

NOMESCO Finland

Right side

2.0

178.0

2447

7386

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.0

178.0

995

1973

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.0

177.9

626

902

SPAT1254

SPAT

Administration of medicine

2.3

177.8

1735

4567

C61

ICD-10 Finland

Malignant neoplasm of prostate

10.4

177.4

273

150

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.7

177.3

4686

17408

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.1

176.7

888

1649

N06AX18

ATC

reboxetine; oral

61.2

175.2

161

J01DA01

ATC

[U] cefalexin

1.6

174.6

9255

40896

M79.1

ICD-10 Finland

Myalgia

2.1

173.8

2203

6447

B01AB10

ATC

tinzaparin; parenteral

3.0

173.6

949

1856

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.9

173.1

633

940

I35.0

ICD-10 Finland

Aortic (valve) stenosis

28.5

171.9

180

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

46.4

171.0

163

N05BA02

ATC

chlordiazepoxide; systemic

16.4

170.6

212

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

10.7

170.6

259

139

F60.5

ICD-10 Finland

Anankastic personality disorder

20.3

170.3

196

UKC02

NOMESCO Finland

Cystoscopy

2.7

170.2

1139

2498

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

170.1

7757

33006

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

169.9

12698

60742

I25

ICD-10 Finland

Chronic ischaemic heart disease

34.6

169.3

170

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

169.1

205

XF600

NOMESCO Finland

Bloodpressure measurement

3.9

169.1

625

936

R55

ICD-10 Finland

Syncope and collapse

2.8

169.0

1019

2110

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

6.5

168.7

359

316

N03AX11

ATC

topiramate; oral

5.5

168.6

418

437

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

165.8

201

SPAT1139

SPAT

Nutrition survey

5.4

165.2

416

442

S97

ICPC

Chronic ulcer skin

5.8

165.1

389

385

ZX114

NOMESCO Finland

Intramuscular

9.0

165.0

277

176

I50.1

ICD-10 Finland

Left ventricular failure

+∞

165.0

200

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

165.0

200

IBA03

NOMESCO Finland

Psychotherapy evaluation

43.1

164.8

159

A12AA04

ATC

calcium carbonate; oral

41.4

164.8

160

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

6.2

164.8

368

343

A10BJ05

ATC

dulaglutide; parenteral

+∞

164.1

199

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

+∞

164.1

199

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

296.5

163.9

208

C01BC04

ATC

flecainide; systemic

29.4

163.4

170

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

11.2

163.4

242

124

HAB40

NOMESCO Finland

Wedge excision of mammary gland

12.0

163.4

233

111

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

199.2

162.5

210

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

162.5

197

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

162.5

197

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

162.1

679

1115

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

24.0

161.7

177

B01AC24

ATC

ticagrelor; oral

+∞

161.6

196

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

161.6

196

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

161.6

196

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

16.0

161.2

202

I50.0

ICD-10 Finland

Congestive heart failure

172.2

161.1

210

Z01.7

ICD-10 Finland

Laboratory examination

2.0

160.6

2071

6088

K02.1

ICD-10 Finland

Caries of dentine

1.6

160.6

10432

47896

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

13.4

159.8

216

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

22.9

159.6

177

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

13.9

159.5

212

B01AF01

ATC

rivaroxaban; oral

3.3

159.5

753

1342

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

159.2

193

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

9.0

158.8

267

170

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

13.8

158.7

212

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

158.5

5270

20677

WX780

NOMESCO Finland

Remote monitoring CPAP

4.0

158.2

563

818

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

15.8

157.9

199

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

27.2

157.6

167

127

Kela drug reimbursment

Transplant complication

27.8

157.6

166

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.2

157.5

753

1353

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.7

157.1

625

989

JHB00

NOMESCO Finland

Hemorrhoidectomy

10.0

156.0

246

141

H3601, E103,

ICD-10 Finland

+∞

155.9

189

F10.20

ICD-10 Finland

Alcohol dependence currently independent

13.2

155.5

212

N06AA04

ATC

clomipramine; systemic

25.2

155.5

168

N05AF01

ATC

flupentixol; systemic

34.2

155.0

156

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

10.8

154.8

233

123

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

24.1

154.5

169

H3603, E103,

ICD-10 Finland

+∞

154.2

187

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

+∞

154.2

187

M01AB05

ATC

diclofenac; systemic, rectal

1.5

154.1

9852

44874

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

30.2

153.9

159

J01EA01

ATC

trimethoprim; systemic

1.8

153.7

3190

10988

D07AC01

ATC

betamethasone; topical

1.6

153.4

4825

18636

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

153.4

3366

11787

L01

ICPC

Neck symptom/complaint

2.0

153.3

2235

6863

C09DA01

ATC

losartan and diuretics; oral

3.3

152.5

716

1271

R03DC03

ATC

montelukast; oral

1.9

152.0

2482

7922

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

8.2

151.4

270

188

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

151.3

1684

4669

B02AA02

ATC

tranexamic acid; systemic

2.0

151.0

2088

6290

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.9

150.3

557

835

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

160.4

149.7

196

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

149.4

816

1593

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.5

149.3

461

595

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

140.6

149.2

197

M01AH05

ATC

etoricoxib; oral

1.5

149.2

9378

42420

H36.01

ICD-10 Finland

Diabetic maculopathy

355.3

148.4

187

WX290

NOMESCO Finland

Other blockage of nerve

1.5

147.4

8607

38270

F50.9

ICD-10 Finland

Eating disorder, unspecified

10.4

147.0

226

124

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

351.4

146.7

185

SFA10

NOMESCO Finland

One-surface restoration

1.5

146.5

9305

42110

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

146.2

1161

2772

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

146.1

1621

4486

R01AD12

ATC

fluticasone furoate; nasal

1.6

145.8

5713

23218

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.1

145.7

392

445

N03AF01

ATC

carbamazepine; oral, rectal

4.2

145.5

489

678

160

Kela drug reimbursment

exenatide

+∞

145.1

176

R52.9

ICD-10 Finland

Pain, unspecified

2.4

144.3

1232

3043

GD1AD

NOMESCO Finland

Thorax CT examination

4.5

144.3

439

559

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

345.6

144.3

182

R13

ICD-10 Finland

Dysphagia

3.2

144.1

697

1261

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.7

143.6

934

2013

J01CA08

ATC

pivmecillinam; oral

1.6

143.6

5960

24526

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.7

143.5

964

2114

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

260.4

143.5

183

R05

ICPC

Cough

1.7

143.3

3254

11481

N17.9

ICD-10 Finland

Acute renal failure, unspecified

10.2

143.3

223

125

R03BB04

ATC

tiotropium bromide; inhalant

3.3

143.1

677

1207

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.9

143.1

514

752

L02BG04

ATC

letrozole; oral

2.9

143.1

818

1640

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.8

143.0

532

800

RD210, ,

NOMESCO Finland

7.5

142.7

272

208

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

+∞

142.6

173

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

142.3

2600

8591

E87.6

ICD-10 Finland

Hypokalaemia

9.5

142.3

231

139

C07AB03

ATC

atenolol; systemic

7.4

142.1

273

211

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.0

141.9

783

1537

WF049

NOMESCO Finland

Radiotherapy of metastasis

339.9

141.8

179

SPAT1281

SPAT

Other administrative function

2.6

141.4

1008

2280

D01

ICPC

Abdominal pain/cramps general

2.0

140.0

1809

5306

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

8.1

139.5

251

177

C10AA04

ATC

fluvastatin; oral

4.7

139.4

406

497

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

+∞

139.3

169

XKD00

NOMESCO Finland

Uroflowmetry

2.6

139.3

970

2167

H02AB04

ATC

methylprednisolone; systemic

2.1

138.6

1630

4612

N06AA10

ATC

nortriptyline; systemic

8.7

138.6

237

155

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.5

138.5

1036

2400

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

17.4

138.5

168

N18.8

ICD-10 Finland

Other chronic renal failure

21.7

138.4

156

EBA15

NOMESCO Finland

Extraction of multiple teeth

5.6

137.7

334

341

A99

ICPC

Disease/condition unspecnature/site

2.5

137.5

1030

2388

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.1

137.5

716

1357

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

137.4

3871

14465

SFA20

NOMESCO Finland

Two-surface restoration

1.5

137.3

9948

46011

ZXA05

NOMESCO Finland

Left side

1.9

137.3

2167

6821

R52.2

ICD-10 Finland

Other chronic pain

4.7

137.1

402

495

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

136.9

166

SPAT1255

SPAT

Intravenous administration of medicine

3.3

136.4

634

1117

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.8

136.3

845

1773

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

10.0

136.2

214

122

SPAT1377

SPAT

Polysomnography

4.4

135.9

424

552

A29

ICPC

General symptom/complaint other

2.3

135.2

1304

3399

SFA30

NOMESCO Finland

Three-surface restoration

1.5

135.1

6024

25105

N05AL01

ATC

sulpiride; systemic

33.6

134.7

136

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

134.6

1125

2749

M70.6

ICD-10 Finland

Trochanteric bursitis

2.4

134.5

1152

2847

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.4

134.4

599

1026

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

+∞

134.4

163

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.6

134.2

397

493

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

962.6

133.9

165

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

28.5

133.6

140

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.2

133.5

634

1133

D11

ICPC

Diarrhoea

2.0

133.4

1893

5739

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.5

133.2

1060

2530

K04

ICPC

Palpitations/awareness of heart

3.4

133.0

593

1016

C50.99

ICD-10 Finland

Breast, unspecified

45.1

132.6

127

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

240.2

132.1

169

WX723

NOMESCO Finland

CPAP therapy

3.7

131.9

518

811

N03AF02

ATC

oxcarbazepine; oral

4.3

131.8

429

579

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.3

131.8

1263

3282

XW000

NOMESCO Finland

Bone marrow biopsy

6.8

131.7

269

225

N06BA12

ATC

lisdexamfetamine; oral

12.9

131.6

181

F41.3

ICD-10 Finland

Other mixed anxiety disorders

7.2

131.6

257

203

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

9.7

131.5

210

123

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

163.1

130.8

171

C01BD01

ATC

amiodarone; systemic

464.1

130.4

163

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

47.0

130.3

124

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

130.2

158

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

162.1

130.0

170

TAB00

NOMESCO Finland

Lumbar puncture

3.2

130.0

620

1111

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

129.1

1627

4721

E23.05

ICD-10 Finland

Lack of TSH

122.6

129.0

172

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

128.8

1003

2368

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

234.4

128.8

165

C09CA03

ATC

valsartan; oral

3.2

128.7

624

1130

IGY02, ,

SPAT

17.4

128.7

156

N05AE04

ATC

ziprasidone; systemic

+∞

128.6

156

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.5

128.6

976

2276

R60.9

ICD-10 Finland

Oedema, unspecified

3.8

128.3

491

754

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

7.8

128.2

236

172

P15

ICPC

Chronic alcohol abuse

5.8

128.1

303

301

F60.8

ICD-10 Finland

Other specific personality disorders

49.1

128.0

121

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

307.2

127.9

162

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

6.7

127.8

264

224

J01FA10

ATC

azithromycin; systemic

1.5

127.6

9948

46380

IGV01

NOMESCO Finland

Psychiatric network contact

305.3

127.1

161

JN4CD

NOMESCO Finland

Very extensive body CT

9.9

126.6

200

115

C50

ICD-10 Finland

Malignant neoplasm of breast

35.8

126.4

126

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

126.1

153

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.4

126.1

241

185

M48.0

ICD-10 Finland

Spinal stenosis

2.8

125.9

759

1567

K59.1

ICD-10 Finland

Functional diarrhoea

3.2

125.7

622

1141

AA400

NOMESCO Finland

Electroconvulsive therapy

898.6

125.6

155

M01AC06

ATC

meloxicam; systemic, rectal

1.6

125.6

4261

16617

I47.2

ICD-10 Finland

Ventricular tachycardia

45.5

125.5

120

F93.89

ICD-10 Finland

Other childhood emotional disorders

301.4

125.4

159

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

125.2

1316

3553

H02AB07

ATC

prednisone; oral

2.1

124.8

1421

3963

K30

ICD-10 Finland

Functional dyspepsia

2.1

124.7

1438

4031

C10AA03

ATC

pravastatin; oral

4.5

124.4

384

495

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

124.4

2355

7841

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

9.1

124.2

207

130

R07.3

ICD-10 Finland

Other chest pain

2.4

123.8

1014

2452

A41.9

ICD-10 Finland

Sepsis, unspecified

6.5

123.8

264

233

A08

ICPC

Swelling

4.5

123.5

374

474

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.1

123.1

643

1220

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

122.7

9591

44574

A10BG03

ATC

pioglitazone; oral

222.9

122.3

157

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.0

122.1

329

374

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

+∞

122.0

148

SPAT1104

SPAT

Monitoring of emergency patient

3.0

121.5

637

1211

T85

ICPC

Hyperthyroidism/thyrotoxicosis

14.4

121.5

159

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

121.3

1264

3399

M02AA07

ATC

piroxicam; topical

1.6

121.2

3783

14438

J01FA09

ATC

clarithromycin; systemic

1.6

120.8

4606

18429

R01AD08

ATC

fluticasone; nasal

1.6

120.3

4382

17348

IHZ05, ,

SPAT

2.9

120.1

673

1332

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

8.3

119.8

212

146

OAA65, ,

SPAT

1.7

119.8

3237

11908

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.4

119.6

372

483

K86

ICPC

Hypertension uncomplicated

2.8

119.5

709

1450

WX722

NOMESCO Finland

PEEP

4.4

119.5

378

498

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

8.3

119.4

211

145

K85

ICPC

Elevated blood pressure

2.3

119.3

1105

2825

L04AA06

ATC

mycophenolic acid; systemic

9.2

119.3

197

122

SPAT1283

SPAT

Restricted health certificate

1.6

119.2

3745

14307

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.0

119.0

633

1214

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

118.7

144

J01CA04

ATC

amoxicillin; systemic

1.6

118.5

13998

70573

SPAT1058

SPAT

PEF monitoring instruction

2.5

118.4

892

2071

3051, ,

Kela drug reimbursment

20.4

118.4

136

Z49.1

ICD-10 Finland

Extracorporeal dialysis

56.3

117.4

109

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

117.2

2830

10096

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

48.5

117.2

111

AN4

Balloon angioplasty and drug eluding stent

+∞

117.0

142

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

+∞

117.0

142

R74

ICPC

Upper respiratory infection acute

1.5

116.5

6020

25676

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

116.4

1102

2844

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

+∞

116.2

141

N17

ICPC

Vertigo/dizziness

2.2

116.0

1192

3185

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.7

115.3

338

416

A04AD12

ATC

aprepitant; systemic

110.4

115.3

155

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.5

114.9

855

1972

CK2S4, ,

SPAT

51.1

114.9

108

5611

FHL

Vena saphena Magna and / or swarm of nodule and possible local emissions

409.5

114.8

144

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

114.7

1085

2799

L02

ICPC

Back symptom/complaint

2.0

114.6

1481

4329

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.1

114.6

593

1118

K59.0

ICD-10 Finland

Constipation

3.2

114.5

558

1013

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

29.4

114.5

119

R4120

NOMESCO Finland

Occupational therapy

3.0

114.5

629

1230

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.7

114.4

444

689

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

114.2

1521

4496

LCA06

NOMESCO Finland

Biopsy of endometrium

2.1

114.0

1397

4003

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

113.9

2937

10656

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

7.0

113.8

229

188

F32.0

ICD-10 Finland

Mild depressive episode

4.2

113.4

371

503

E83.51

ICD-10 Finland

Hypocalcemia

29.2

113.3

118

A11

ICPC

Chest pain NOS

2.9

113.2

661

1339

R06.5

ICD-10 Finland

Mouth breathing

2.2

113.2

1183

3183

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

21.9

113.0

127

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

6.6

113.0

238

207

N19

ICD-10 Finland

Unspecified kidney failure

9.2

112.7

186

115

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

112.6

787

1758

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

112.5

1026

2604

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.4

112.3

495

841

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.1

112.2

1230

3374

L15

ICPC

Knee symptom/complaint

1.7

112.1

2832

10215

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.2

111.9

548

998

L08

ICPC

Shoulder symptom/complaint

1.7

111.8

2498

8710

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

790.9

111.7

138

R4110, ,

SPAT

2.5

111.5

855

2001

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.1

111.4

559

1034

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.8

111.2

663

1359

R03BA02

ATC

budesonide; inhalant

1.7

111.2

2370

8152

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

111.0

619

1221

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

110.8

6008

25806

WX882

NOMESCO Finland

High dependency care

6.2

110.7

245

226

TKC20

NOMESCO Finland

Catheterisation of bladder

3.7

110.6

434

679

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.2

110.4

367

504

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

110.4

134

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

38.4

109.7

108

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

29.4

109.7

114

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

109.7

1200

3288

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

109.6

133

A10AB06

ATC

insulin glulisine; parenteral

+∞

109.6

133

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

+∞

109.6

133

M01AH01

ATC

celecoxib; oral

1.9

109.6

1716

5363

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

12.4

109.5

153

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

13.5

109.3

147

T99

ICPC

Endocr/metab/nutrit disease other

7.5

109.3

207

157

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

9.9

109.2

173

100

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

109.0

1948

6353

M10.9

ICD-10 Finland

Gout, unspecified

3.8

108.7

403

604

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

108.6

1944

6343

R01AD58

ATC

fluticasone, combinations; nasal

1.5

108.5

4345

17499

C02EA02, ,

ATC

56.8

107.8

100

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

25.4

107.6

116

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

383.7

107.4

135

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

11.2

107.4

158

ZX090

NOMESCO Finland

Other technic of radiotherapy

116.3

106.9

143

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

2.0

106.7

1512

4564

C09DA06

ATC

candesartan and diuretics; oral

3.2

106.5

518

939

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

106.5

2959

10924

R03BA05

ATC

fluticasone; inhalant

1.7

106.5

2551

9058

N05AA01

ATC

chlorpromazine; systemic, rectal

102.5

106.5

144

G04BD12

ATC

mirabegron; oral

2.6

106.0

743

1662

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

12.3

106.0

149

S29

ICPC

Skin symptom/complaint other

1.8

105.9

2168

7363

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.3

105.9

492

866

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.9

105.8

588

1157

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.0

105.8

1306

3749

107

Kela drug reimbursment

Pernicious anaemia

+∞

105.5

128

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.9

105.4

602

1204

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

105.2

878

2139

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

253.5

105.0

134

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

253.5

105.0

134

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

9.1

105.0

175

110

C05AA08

ATC

fluocortolone; rectal, topical

2.0

104.5

1425

4242

OAB72

NOMESCO Finland

Weight control and weight loss guidance

10.5

104.3

159

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

734.6

104.3

129

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

104.2

4286

17336

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

12.9

104.2

143

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

104.1

2794

10218

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.3

103.9

960

2449

K90

ICPC

Stroke/cerebrovascular accident

30.4

103.7

107

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

103.6

858

2082

J01MA14

ATC

moxifloxacin; systemic

2.4

103.5

881

2166

F10.24

ICD-10 Finland

Alcohol depence active use

12.7

103.4

143

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

5.2

103.1

268

294

L13

ICPC

Hip symptom/complaint

1.9

103.1

1624

5080

FN1AD

NOMESCO Finland

CT of coronary arteries

+∞

103.0

125

116

Kela drug reimbursment

Prostate cancer

+∞

103.0

125

G03DB01

ATC

dydrogesterone; oral

1.8

102.7

1851

6046

I42.0

ICD-10 Finland

Dilated cardiomyopathy

247.7

102.6

131

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

18.6

102.2

121

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

5.7

102.2

243

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.5

101.9

776

1809

EBA00

NOMESCO Finland

Extraction of tooth

1.5

101.9

5452

23260

R96

ICPC

Asthma

2.2

101.8

1028

2724

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

19.7

101.7

118

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

11.6

101.7

147

4CJ01, ,

NOMESCO Finland

+∞

101.3

123

IEY01

NOMESCO Finland

Psychoeducation, individual

87.9

101.3

139

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

710.7

101.0

125

P20

ICPC

Memory disturbance

3.0

100.9

525

993

C08DB01

ATC

diltiazem; oral

10.4

100.9

155

IER01

NOMESCO Finland

Psychoeducation, group

127.1

100.9

134

D06

ICPC

Abdominal pain localized other

2.1

100.9

1199

3391

N01

ICPC

Headache

1.8

100.8

1997

6710

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

100.8

3120

11814

Z08

ICPC

Social welfare problem

12.8

100.7

139

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

6.3

100.7

219

198

C07AA07

ATC

sotalol; systemic

11.2

100.6

148

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.0

100.6

348

494

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

+∞

100.5

122

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

+∞

100.5

122

B03XA02

ATC

darbepoetin alfa; parenteral

87.3

100.5

138

A12BA01

ATC

potassium chloride; oral

109.7

100.4

135

UJH02

NOMESCO Finland

Anoscopy

4.3

100.3

323

432

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

35.5

100.1

100

J45

ICD-10 Finland

Asthma

2.0

100.1

1357

4029

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

100.1

3485

13564

F10.25

ICD-10 Finland

Alcohol dependence continuous use

10.6

99.8

152

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

99.8

3972

15928

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

9.4

99.5

162

C07AB12

ATC

nebivolol; oral

5.3

99.5

256

278

SPAT1054

SPAT

Examination of peripheral nervous system

23.8

99.4

109

I49.5

ICD-10 Finland

Sick sinus syndrome

699.2

99.3

123

N06AX17

ATC

milnacipran; oral

240.1

99.3

127

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

355.0

99.2

125

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

20.2

99.1

114

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

99.0

1149

3219

S06.0

ICD-10 Finland

Concussion

2.0

99.0

1327

3924

-50

ICPC

Medication/prescr/renewal

3.5

98.7

407

660

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

98.6

602

1250

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

22.3

98.5

110

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

98.5

1653

5276

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6747

24302

1.92

322.35

3.5

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1418

2452

3.46

318.50

1.7

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1441

2525

3.42

317.46

1.8

1.2

—

(3042936) Bacteria identified in Isolate by Culture

2170

4883

2.72

316.65

2.2

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

2167

4883

2.72

315.32

1.8

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1557

2908

3.22

311.40

3.1

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1572

2955

3.20

311.26

2.8

2.2

10.59

10.85

g/l

1.70

1434

2714

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2928

7726

2.37

309.55

1.9

1.4

1.43

1.16

79.16

2617

7236

(3000991) Gas panel - Venous blood

1256

1354

5.56

307.65

10.8

5.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9702

28356

3.07

307.65

3.5

2.2

91.22

67.94

ug/l

31.36

9163

27098

(3000850) Epithelial cells [#/volume] in Urine

3256

7782

2.67

307.65

2.6

1.8

6.76

6.69

e6/l

0.08

2938

6757

(3015377) Calcium [Moles/volume] in Serum or Plasma

5801

9585

4.60

307.65

3.3

1.4

2.33

2.35

mmol/l

14.11

5304

8546

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2207

4219

3.23

307.65

1.9

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8300

13761

5.54

307.65

8.1

3.0

1.21

1.22

mmol/l

40.43

6984

11890

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1490

1500

6.04

307.65

9.5

5.0

5.08

4.96

kpa

3.99

1430

1422

(3027945) Reticulocytes/100 erythrocytes in Blood

1534

2000

4.65

307.65

3.1

1.9

1.74

1.42

24.75

1368

1786

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

942

196

28.62

307.65

6.5

1.2

69.76

172.98

u/ml

0.62

383

(3014111) Lactate [Moles/volume] in Serum or Plasma

1271

1428

5.34

307.65

9.3

4.5

1.34

mmol/l

0.05

1242

1395

(3013512) EKG study

4070

8118

3.38

307.65

3.4

1.7

—

(3013115) Eosinophils [#/volume] in Blood

9129

27349

2.83

307.65

6.8

4.7

0.20

0.19

e9/l

4.13

8229

24791

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

373

22.87

307.65

5.9

2.1

0.33

0.31

u/ml

0.16

210

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3720

6060

4.13

307.65

1.7

1.3

35916362.11

50652197.05

pmol/l

0.57

3188

5370

(3015736) pH of Urine

6892

23590

2.07

307.65

3.1

2.2

5.95

5.94

0.01

678

3207

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4671

8223

4.00

307.65

2.3

1.8

2.71

2.40

mg/l

18.26

4001

7036

(3002385) Erythrocyte distribution width [Ratio]

14349

64351

2.39

307.65

16.6

5.9

14.45

14.52

0.14

14141

62814

(3006504) Eosinophils/100 leukocytes in Blood

8170

24853

2.59

307.65

6.6

4.7

2.91

2.90

0.13

7690

23522

(40761511) CBC panel - Blood by Automated count

16769

79574

4.81

307.65

13.6

4.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15395

72054

2.62

307.65

4.8

2.6

2.85

3.06

mmol/l

163.59

14587

68684

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4263

11731

2.39

307.65

1.8

1.4

1.51

1.23

mmol/l

44.10

3589

10475

(3037522) Nuclear Ab [Titer] in Serum

2998

7202

2.63

307.65

1.4

1.3

538.34

580.71

titre

0.48

639

1348

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1672

1314

7.83

307.65

4.0

2.7

73.56

66.16

ng/l

1.26

1503

1187

(3024354) Oxygen [Partial pressure] in Venous blood

1101

1364

4.80

307.65

4.8

2.3

4.80

4.78

kpa

0.07

1059

1328

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1676

2097

4.88

307.65

5.1

2.3

228.27

219.01

u/l

2.29

1599

1986

(3022217) INR in Platelet poor plasma by Coagulation assay

6071

11719

3.94

307.65

9.6

2.0

1.10

1.03

inr

15.92

2063

3822

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5555

14341

2.73

307.65

1.4

1.2

1.46

1.99

u/ml

2.54

1752

4319

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2382

2884

5.24

307.65

2.8

1.6

24.13

27.26

14.19

2033

2520

(3021589) Normoblasts [#/volume] in Blood

7904

24129

2.54

307.65

10.0

5.3

0.00

e9/l

0.26

6650

20111

(3019225) pH of Specimen

1561

2598

3.63

307.65

4.7

2.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5434

12353

3.14

307.65

3.1

1.7

56.42

59.68

u/l

1.34

5024

11490

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11866

50652

1.99

307.65

3.5

2.0

43.31

30.53

u/l

58.30

11313

48815

(3016502) Oxygen saturation in Arterial blood

1349

1241

6.56

307.65

10.2

5.4

96.04

96.44

0.81

1301

1182

(3029937) Albumin [Presence] in Urine by Test strip

4832

15196

2.10

307.65

3.8

2.5

0.00

estimate

0.05

1914

5242

(3012516) Albumin [Mass/volume] in Urine

4274

4464

6.82

307.65

3.8

1.9

491.75

775.02

mg/l

1.40

2834

2416

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

737

685

6.30

307.65

12.9

6.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

465

181

14.87

307.65

6.4

2.9

392.64

395.68

umol/l

0.09

412

152

(3009261) Glucose [Presence] in Urine by Test strip

8487

30537

2.10

307.65

3.5

2.4

0.00

estimate

0.96

1890

5276

(3002030) Lymphocytes/100 leukocytes in Blood

8560

26711

2.57

307.65

6.6

4.6

29.71

31.02

24.79

8103

25452

(3001019) Free T4 and TSH panel - Serum or Plasma

2668

5079

3.32

307.65

2.6

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2896

3879

4.85

307.65

2.7

1.6

14.37

21.80

umol/l

0.82

2684

3661

(3001604) Monocytes [#/volume] in Blood

8799

26100

2.80

307.65

6.5

4.7

0.55

0.53

e9/l

15.64

7845

23444

(3028707) Methadone [Presence] in Urine by Screen method

701

424

9.68

307.65

2.9

1.8

—

(3023368) Bacteria identified in Blood by Culture

3518

6899

3.35

307.65

4.4

2.3

—

(3026008) Bacteria identified in Urine by Culture

4377

12350

2.33

307.65

2.5

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4335

1742

18.30

307.65

4.6

2.9

4.59

4.80

pmol/l

9.95

3949

1599

(3021960) Folate [Moles/volume] in Serum or Plasma

3533

5568

4.23

307.65

1.5

1.2

19.77

21.42

nmol/l

7.62

3142

4799

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1022

998

6.08

307.65

2.3

1.2

7.94

3.17

ug/l

5.98

914

862

(3020779) Urea [Moles/volume] in Serum or Plasma

1342

1196

6.78

307.65

10.5

3.5

8.32

6.09

mmol/l

24.02

1284

1136

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1073

1315

4.84

307.65

4.1

2.9

5.12

5.09

kpa

0.36

1028

1255

(3030467) Casts [#/volume] in Urine by Automated count

4084

10559

2.54

307.65

3.1

2.0

0.27

0.24

e6/l

0.48

3146

7432

(40760892) CBC W Ordered Manual Differential panel - Blood

8466

24373

2.85

307.65

6.9

5.0

—

(3003396) Base excess in Arterial blood by calculation

1505

1500

6.10

307.65

9.5

4.9

0.73

0.82

mmol/l

0.27

1173

1081

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2175

3249

4.17

307.65

2.8

1.5

29.81

28.65

12.04

2105

3138

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6138

15363

2.93

307.65

3.3

2.1

31.09

28.51

u/l

3.54

5835

14765

(3013707) Erythrocyte sedimentation rate by Westergren method

12591

42866

3.30

307.65

4.1

2.9

9.71

7.47

mm/h

86.56

11802

40202

(3009508) Creatinine [Moles/volume] in Urine

5111

6651

5.70

307.65

3.8

1.9

8.20

8.84

mmol/l

9.77

4509

6028

(3019060) Gas panel - Arterial blood

826

790

6.15

307.65

6.3

3.1

—

(3006315) Basophils [#/volume] in Blood

8824

26129

2.81

307.65

6.5

4.7

0.04

e9/l

1.68

7850

23445

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

827

799

6.08

307.65

3.4

1.3

115.86

35.92

ng/l

14.41

726

688

(3013826) Glucose [Moles/volume] in Serum or Plasma

9397

23558

3.68

307.65

5.4

2.4

6.64

5.86

mmol/l

155.74

8644

20104

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1562

1630

5.84

307.65

4.2

1.7

1.22

1.23

mmol/l

7.76

1358

1362

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14720

68317

2.31

307.65

4.0

2.4

1.37

1.17

mmol/l

140.51

13912

65452

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

17303

58262

35.35

307.65

11.5

2.3

2.47

2.31

mu/l

0.32

16701

54388

(3008152) Bicarbonate [Moles/volume] in Arterial blood

838

819

6.02

307.65

8.4

4.1

24.30

24.31

mmol/l

0.01

796

767

(3035637) Corticotropin [Mass/volume] in Plasma

525

254

12.00

307.65

1.8

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

3876

8996

2.84

307.65

4.2

2.2

96.28

97.46

2.11

3737

8726

(3031040) Bacteria [#/volume] in Urine by Automated count

10583

38499

2.38

307.65

4.2

2.8

1523.09

1273.46

e6/l

0.17

154

389

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1479

1921

4.65

307.65

2.6

2.3

0.23

0.24

g/l

4.38

1380

1816

(3044640) Blood type and Crossmatch panel - Blood

5205

14769

2.40

307.65

2.3

1.5

—

(40758558) Short blood count panel - Blood

4300

10773

2.66

307.65

7.2

3.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

16089

62856

6.04

307.65

14.6

3.8

139.54

139.80

mmol/l

37.11

15704

60324

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5337

11117

3.45

307.65

3.2

1.4

41.70

10.64

ng/l

5.55

2770

3513

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2727

4449

3.91

307.65

2.8

1.5

2.41

2.40

mmol/l

2.61

2408

3799

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

433

167

14.99

307.65

3.4

2.3

0.93

0.80

nmol/l

1.33

340

156

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8240

18528

3.84

307.65

6.1

2.5

10.11

11.36

umol/l

11.91

7725

17268

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4898

3636

10.15

307.65

1.3

1.2

217.78

93.42

iu/ml

47.32

2256

1304

(3002032) Base excess in Venous blood by calculation

1369

1563

5.28

307.65

5.1

2.4

1.63

1.89

mmol/l

1.63

1143

1318

(3009343) pH of Capillary blood

1058

1303

4.81

307.65

4.1

2.9

7.41

7.43

3.47

146

(3026782) Osmolality of Urine

3131

7148

2.79

307.65

2.9

1.9

539.05

577.20

mosm/kgh2o

12.40

2709

5955

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7799

26441

2.19

307.65

2.6

2.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7498

11919

5.44

307.65

7.4

2.8

1.21

1.22

mmol/l

29.33

6942

10717

(40768797) Stomach Pathology biopsy report

2340

5154

2.80

307.65

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

416

24.28

307.65

2.5

1.9

160.98

81.69

ug/min

0.84

288

(3013650) Neutrophils [#/volume] in Blood by Automated count

9929

29177

3.11

307.65

9.9

4.8

3.95

3.88

e9/l

1.92

8873

25796

(3012544) pH of Venous blood

1399

1617

5.22

307.65

5.2

2.3

7.36

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2778

2769

6.54

307.65

4.0

1.9

0.82

0.86

mmol/l

23.06

2617

2591

(3007164) IgA [Mass/volume] in Serum or Plasma

4601

12025

2.57

307.65

1.5

1.3

2.18

2.13

g/l

1.52

2957

8120

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15274

71743

2.50

307.65

4.5

2.6

4.71

4.98

mmol/l

219.74

14523

68825

(3018010) Neutrophils/100 leukocytes in Blood

8442

26350

2.55

307.65

6.4

4.5

55.82

55.19

5.46

7984

25131

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2303

2311

6.32

307.65

7.1

3.5

1.06

1.04

mmol/l

1.69

2159

2144

(36304419) Bacteria [Presence] in Urine

4087

10918

2.45

307.65

3.0

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6408

12296

4.05

307.65

1.9

1.3

98.19

100.26

pmol/l

2.27

3682

6354

(3044889) 12 lead EKG panel

10644

32220

3.18

307.65

3.4

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16733

78087

5.04

307.65

11.0

4.6

27.80

25.51

u/l

32.17

16327

75382

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2987

2414

8.21

307.65

2.7

1.6

371.10

381.83

nmol/l

1.36

2745

2264

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12458

36101

4.23

307.65

7.7

3.8

74.59

70.60

u/l

24.75

11812

33725

(3018095) Leukocytes [#/volume] in Urine

5454

16274

2.29

307.65

3.7

2.3

62.85

65.08

e6/l

0.11

3815

9812

(3024561) Albumin [Mass/volume] in Serum or Plasma

6732

13176

4.05

307.65

5.2

3.1

36.64

37.88

g/l

53.20

6289

12202

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3898

10694

2.36

307.65

2.3

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1824

3610

3.07

307.65

2.0

1.4

337.71

267.87

mu/l

8.04

1619

3307

(3037467) Urinalysis macro (dipstick) panel - Urine

11168

42252

2.34

307.65

4.3

2.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15011

63335

3.26

307.65

4.4

2.3

5.86

5.35

mmol/l

293.02

14112

59497

(3018418) pH of Serum or Plasma

5137

7256

5.23

307.65

5.1

1.9

7.39

7.40

1.68

1143

1083

(3019309) Folate [Moles/volume] in Red Blood Cells

2795

3385

5.35

307.65

1.8

1.4

1174.20

1144.10

nmol/l

0.75

2223

2508

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1375

1581

5.24

307.65

5.1

2.4

5.85

5.84

kpa

0.05

1322

1537

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14225

55144

3.35

307.65

5.8

2.2

39.31

35.41

mmol/mol

307.65

13455

52315

(3004119) Hemoglobin [Mass/volume] in Venous blood

861

920

5.51

307.65

4.6

1.9

131.64

140.94

g/l

19.56

837

906

(4035726) Immunohistochemistry procedure

1259

1427

5.29

307.65

1.4

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2614

3274

5.12

307.65

2.7

1.5

2.45

2.53

g/l

7.27

2391

3050

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

714

168.05

307.65

8.0

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1509

969

9.52

307.65

2.4

2.0

5.38

3.38

iu/l

8.27

726

408

(3035350) Ketones [Presence] in Urine by Test strip

8449

30178

2.11

307.65

3.5

2.4

0.00

estimate

0.35

2014

5404

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3102

2946

7.00

307.65

3.2

1.3

859.03

162.90

ng/l

15.78

2470

2102

(3023520) Reticulocytes [#/volume] in Blood

1105

1179

5.58

307.65

2.9

1.8

73.71

65.42

e9/l

7.83

836

857

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4006

9350

2.84

307.65

2.1

1.4

1.01

0.79

mg/l

2.52

2948

6693

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1034

1265

4.84

307.65

4.1

2.9

1.18

1.06

mmol/l

0.41

744

894

(3019198) Lymphocytes [#/volume] in Blood

9157

27717

2.80

307.65

6.5

4.6

1.99

1.98

e9/l

0.47

8346

25390

(3020630) Protein [Mass/volume] in Serum or Plasma

1055

1322

4.73

307.65

2.8

1.3

66.44

68.67

g/l

12.85

983

1233

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4620

8257

3.93

307.65

2.3

1.5

189.24

210.66

u/l

0.47

4372

7803

(3023103) Potassium [Moles/volume] in Serum or Plasma

16130

63292

6.10

307.65

14.7

3.9

3.93

mmol/l

0.35

15713

60523

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17161

45585

41.57

307.65

10.1

2.0

15.15

14.19

pmol/l

307.65

16618

41688

(3022096) Basophils/100 leukocytes in Blood

7897

23819

2.58

307.65

6.6

4.8

0.68

0.69

0.42

7397

22441

(3027801) Oxygen [Partial pressure] in Arterial blood

1490

1499

6.04

307.65

9.5

5.0

12.71

14.30

kpa

12.67

1429

1423

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2410

4411

3.42

307.65

3.6

1.5

316.29

37.40

ng/l

6.40

1455

1890

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

14993

61565

3.49

307.65

11.7

3.9

91.82

92.55

ml/min/173m2

3.73

12574

47565

(3020682) Albumin/Creatinine [Ratio] in Urine

4460

4694

6.84

307.65

4.5

2.1

10.49

16.88

mg/mmol

0.84

2973

2615

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16069

71184

4.07

307.65

13.7

5.1

18.12

20.98

mg/l

24.30

13066

49045

(3026493) Urate [Moles/volume] in Serum or Plasma

4213

11311

2.45

307.65

2.5

1.6

2444.54

3542.39

umol/l

1.34

3789

10451

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1251

1166

6.45

307.65

10.4

5.7

125.19

128.12

g/l

3.10

1221

1124

(3019069) Monocytes/100 leukocytes in Blood

8220

25033

2.60

307.65

6.9

4.8

8.22

8.10

2.97

7745

23753

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15178

71359

2.44

307.65

4.4

2.6

1.41

1.53

mmol/l

220.32

14393

68494

(3021601) Nitrite [Presence] in Urine by Test strip

8426

30236

2.10

307.65

4.6

3.3

0.00

estimate

2.81

1973

5318

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8060

19146

3.54

307.65

2.5

1.9

73.29

75.27

nmol/l

7.36

7521

17977

(3009214) Lutropin [Units/volume] in Serum or Plasma

1514

2434

3.75

307.65

1.5

1.3

8.28

7.75

u/l

0.64

1233

2062

(3002582) Erythrocytes [#/volume] in Urine

4497

11990

2.50

307.65

3.3

2.0

82.09

67.37

e6/l

0.21

3509

8603

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1028

1224

4.97

307.65

8.6

5.2

24.55

24.61

mmol/l

0.17

1020

1219

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1896

4022

2.86

307.22

2.7

1.9

6.72

6.10

umol/l

0.67

1618

3456

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

450

235

11.07

301.15

1.2

1.1

2067.36

8.06

iu/ml

0.54

134

(40768804) Tissue Pathology biopsy report

6468

23369

1.89

300.80

2.0

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3494

10089

2.19

299.20

1.3

1.2

28.55

29.87

iu/ml

0.06

1052

3458

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

683

657

6.07

298.33

12.8

7.1

24.17

24.28

mmol/l

0.32

666

642

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3338

9511

2.21

294.65

1.3

1.2

9.63

11.47

u/ml

0.77

1449

4232

(3009542) Hematocrit [Volume Fraction] of Blood

17402

90080

7.45

287.84

21.9

7.0

40.66

41.69

7.12

16710

85463

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

662

640

6.03

287.79

1.3

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

535

404

7.68

283.74

2.8

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1863

4095

2.75

282.15

6.1

2.4

—

(3007461) Platelets [#/volume] in Blood

17409

90283

7.49

281.97

21.8

7.1

262.33

256.87

e9/l

24.80

17180

87550

(3017181) Myelocytes/100 leukocytes in Blood

1561

3134

2.99

276.74

4.4

3.8

0.96

0.46

7.96

475

530

(3035941) MCH [Entitic mass]

17412

90514

7.38

273.24

21.6

7.0

30.07

0.06

17286

89181

(3004588) Protein electrophoresis panel - Serum or Plasma

806

1006

4.69

272.14

2.4

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

767

915

4.90

271.86

5.7

2.4

23.85

24.30

mmol/l

3.05

757

910

(3024731) MCV [Entitic volume]

17410

90531

7.31

271.67

21.7

7.0

90.08

89.70

23.80

17285

89186

(3026361) Erythrocytes [#/volume] in Blood

17412

90559

7.34

271.30

21.7

7.0

4.57

4.62

e12/l

45.38

17155

87681

(3010813) Leukocytes [#/volume] in Blood

17412

90598

7.31

269.62

21.8

7.1

6.72

6.46

e9/l

45.45

17151

87670

(3027273) Bicarbonate [Moles/volume] in Venous blood

674

714

5.50

269.16

4.1

2.2

25.01

25.41

mmol/l

1.96

643

685

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1911

4377

2.64

267.30

3.2

1.8

11.31

13.79

nmol/l

26.92

1742

4180

(3000963) Hemoglobin [Mass/volume] in Blood

17413

90664

7.28

267.19

21.9

7.1

136.58

138.64

g/l

78.32

17285

89337

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

282

26.96

265.35

1.5

1.2

14.51

13.59

pmol/l

0.85

239

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

958

1448

3.89

257.37

3.7

1.9

26.59

2.22

ug/l

1.25

730

940

(3010421) pH of Blood

523

439

6.90

255.80

3.7

2.0

7.41

7.42

0.85

478

415

(3028026) IgM [Mass/volume] in Serum or Plasma

1211

2179

3.30

254.93

1.8

1.6

1.21

1.27

g/l

0.64

1118

2039

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1095

1845

3.51

253.81

1.6

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1446

2925

2.95

252.33

4.1

3.6

0.67

0.44

1.46

412

488

(3021440) Promyelocytes/100 leukocytes in Blood

1482

3077

2.88

247.13

4.4

3.8

0.06

0.03

1.38

392

471

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2341

6163

2.32

244.24

2.7

1.9

1.03

0.88

e6/l

1.08

1321

3300

(1616796) Gas panel - Central venous blood

454

341

7.69

241.54

3.4

2.0

—

(3022313) Gas panel - Capillary blood

760

1000

4.44

241.52

3.9

3.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

610

656

5.40

239.88

2.1

1.8

1.37

1.09

g/l

8.09

520

569

(3023183) Ammonium ion [Moles/volume] in Plasma

394

243

9.34

239.27

3.2

2.8

34.50

34.66

umol/l

0.03

369

223

(3020891) Body temperature

547

528

6.01

237.80

5.8

3.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1852

4420

2.53

237.59

1.4

1.3

20.98

25.45

iu/l

6.17

1557

3906

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

608

669

5.28

233.74

4.8

2.4

51.84

48.54

1.60

597

663

(3025159) Blasts/100 leukocytes in Blood

1427

2993

2.84

233.32

4.4

3.8

0.05

0.02

0.94

335

404

(3018405) Lactate [Moles/volume] in Arterial blood

479

405

6.84

232.82

4.7

2.9

1.31

1.35

mmol/l

0.26

472

400

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

541

531

5.90

231.67

2.6

1.9

464.88

438.90

ug/l

0.07

494

471

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1510

3302

2.73

228.87

2.6

1.8

35.82

42.35

u/l

1.27

1292

2874

(3027315) Oxygen [Partial pressure] in Blood

454

369

7.11

227.61

3.7

1.9

9.01

9.30

kpa

1.84

448

364

(3012501) Base excess in Blood by calculation

452

369

7.07

225.82

3.7

1.9

2.21

1.75

mmol/l

2.35

289

209

(3013290) Carbon dioxide [Partial pressure] in Blood

452

369

7.07

225.82

3.7

2.0

5.04

4.95

kpa

1.31

446

364

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2217

5886

2.29

225.76

3.0

1.9

3.63

3.34

e6/l

0.48

1196

3045

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

478

445

6.21

214.39

2.3

1.6

1.83

1.65

ug/l

0.14

428

381

(3019150) Specific gravity of Urine by Refractometry

3657

12014

1.91

212.79

3.8

2.4

1.02

1.01

kg/l

1.42

493

2064

(3011985) Renin [Units/volume] in Plasma

337

198

9.78

210.71

2.4

1.6

80.31

45.67

mu/l

1.42

311

188

(3041096) Erythrocytes [Presence] in Urine by Automated

5035

18383

1.77

208.76

3.0

2.1

—

(40761536) Microorganisms panel - Urine sediment

1843

4658

2.38

208.41

3.5

2.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

425

356

6.88

208.03

4.1

2.4

24.07

24.25

mmol/l

0.32

418

351

(3011397) Hemoglobin [Presence] in Urine by Test strip

3709

12389

1.87

204.18

3.5

2.5

—

(3036489) Thrombin time

722

1047

4.02

203.82

2.6

1.6

20.83

20.34

1.81

591

855

(3048689) Calprotectin [Mass/mass] in Stool

2781

8434

2.02

201.86

2.2

2.9

125.93

118.23

ug/g

0.43

2159

6857

(36660697) Celiac disease serology panel - Serum

1903

5006

2.29

196.28

1.2

1.1

—

(3002256) Pathology report gross observation

2048

5568

2.22

195.62

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

705

1046

3.92

193.24

1.6

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

387

318

7.00

192.27

2.7

1.5

17.14

18.65

6.38

202

127

(44816559) Phosphatidylethanol [Mass/volume] in Blood

528

613

4.98

192.00

1.4

1.2

—

(3008295) Osmolality of Serum or Plasma

268

126

12.18

189.19

1.9

1.6

286.64

285.35

mosm/kgh2o

0.27

222

105

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

639

896

4.14

187.90

3.5

1.7

94.01

92.46

0.72

611

838

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

672

983

3.97

187.49

4.0

3.1

24.59

24.54

mmol/l

0.17

631

941

(3017143) Hepatitis C virus Ab [Presence] in Serum

3045

9806

1.91

184.94

1.7

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

521

622

4.84

183.94

6.7

2.7

1.68

1.61

0.51

491

577

(3000570) Elastase.pancreatic [Mass/mass] in Stool

519

622

4.82

182.48

1.5

1.2

290.05

344.18

ug/g

4.83

277

312

(3007930) Methemoglobin/Hemoglobin.total in Blood

507

601

4.88

180.33

7.0

2.8

0.93

0.92

0.08

478

560

(3021901) Oxygen saturation in Capillary blood

312

209

8.56

179.59

2.9

2.2

—

(3003181) Sodium [Moles/volume] in Urine

264

136

11.11

177.77

2.1

1.6

73.05

76.00

mmol/l

0.20

216

114

(3015171) Extractable nuclear Ab [Units/volume] in Serum

953

1864

3.00

174.32

1.3

1.2

0.89

0.71

u/ml

0.18

119

(40761535) Cells panel - Urine sediment

1242

2824

2.60

173.28

3.4

2.4

—

(3022145) Colonoscopy Study observation

1846

5066

2.18

171.12

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method

996

2042

2.86

168.03

3.0

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

706

1191

3.45

162.23

2.0

1.9

0.23

0.22

g/l

3.87

665

1136

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

306

233

7.53

161.03

1.6

1.4

—

(4146454) Self-monitoring of blood glucose

166

30.52

161.01

3.5

1.4

—

(3000494) Fungus identified in Specimen by Culture

1978

5720

2.07

160.17

1.5

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

719

1243

3.36

159.39

2.0

1.8

1.19

1.11

g/l

7.05

678

1189

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

577

864

3.87

156.01

5.0

3.0

1.36

1.04

mg/l

19.32

540

818

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

574

860

3.86

155.08

2.9

2.0

171.66

152.71

4.54

540

798

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

423

493

4.94

153.06

1.3

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

735

1327

3.22

152.53

2.3

1.7

187.73

205.71

pmol/l

3.16

704

1292

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

271

188

8.25

152.34

1.5

1.2

1179.60

312.77

pmol/l

1.01

236

167

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1236

2995

2.43

151.02

2.7

1.5

72.35

84.44

ml/min/173m2

15.39

492

849

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

840

1659

2.95

150.82

2.0

39.54

40.93

u/l

1.14

778

1600

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

432

522

4.77

150.45

5.3

2.3

1214.31

907.28

iu/ml

0.12

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

737

1357

3.16

148.29

1.7

1.4

0.45

0.54

nmol/l

0.82

612

1166

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

632

1053

3.48

147.71

1.8

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

335

319

6.03

147.17

3.0

1.7

628.47

50947.64

u/ml

0.48

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

972

2136

2.66

144.14

1.1

17.52

6.91

u/ml

0.31

(3009445) Proteinase 3 Ab [Units/volume] in Serum

724

1342

3.13

144.10

1.6

8.99

11.99

u/ml

0.45

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

871

1805

2.81

143.79

1.6

1.5

—

(3024928) Oxygen saturation in Venous blood

307

273

6.45

143.03

5.4

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

627

1064

3.41

142.68

1.5

1.2

17.21

19.61

u/l

1.10

526

902

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

193

12.80

139.83

1.8

3.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

319

305

6.00

139.63

4.0

1.6

69.78

22.49

mg/l

0.65

251

250

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

394

476

4.76

137.21

1.8

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

308

289

6.11

137.06

3.9

1.5

1.29

1.15

ratio

0.65

(3034860) Kappa light chains.free [Mass/volume] in Serum

317

308

5.90

136.78

4.1

1.6

39.94

26.43

mg/l

4.03

248

252

(3047181) Lactate [Moles/volume] in Blood

465

651

4.12

136.74

7.4

2.6

1.31

1.16

mmol/l

2.07

405

572

(3028626) Oxygen [Partial pressure] in Capillary blood

431

583

4.25

132.09

4.1

4.0

8.98

9.31

kpa

2.60

420

572

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

723

1418

2.96

131.10

2.1

1.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1839

5553

1.97

130.97

2.4

2.1

6531.57

6897.88

u/l

0.17

719

2623

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

279

246

6.49

130.91

1.5

1.3

0.16

0.11

nmol/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

377

459

4.72

130.18

1.9

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

281

257

6.26

127.85

1.5

1.3

0.51

0.50

nmol/l

0.16

272

246

(3003694) ABO and Rh group [Type] in Blood

5619

23299

1.53

126.93

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

983

2316

2.48

126.77

2.2

1.5

38.33

43.22

nmol/l

5.45

963

2297

(3020961) Endomysium IgA Ab [Titer] in Serum

1308

3515

2.19

125.92

1.2

1.1

78.19

202.97

titre

2.55

120

(3007566) Smooth muscle Ab [Titer] in Serum

617

1128

3.16

125.34

1.3

1.4

104.67

124.44

titre

0.17

108

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

259

224

6.61

123.47

1.5

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

599

1088

3.18

122.91

1.3

1020.00

1332.11

titre

0.36

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

475

737

3.71

122.40

2.0

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

609

1126

3.13

121.51

1.8

1.6

471.54

394.29

titre

0.15

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

356

440

4.64

120.92

1.1

1.0

119.26

117.55

0.38

318

376

(40760888) Immunoglobulin light chains.free panel - Serum

257

228

6.45

119.98

4.1

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

258

230

6.41

119.96

1.4

1.3

—

nmol/l

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

572

1025

3.22

119.83

3.6

1.9

3.63

3.60

g/l

0.11

540

965

(3039000) Anion gap in Blood

299

316

5.42

119.31

9.7

3.7

11.38

11.50

mmol/l

0.17

273

275

(3018572) Chloride [Moles/volume] in Blood

299

317

5.40

118.95

9.7

3.7

105.74

105.48

mmol/l

0.34

274

276

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2568

8932

1.73

116.37

1.9

2.0

—

(3036180) Methadone [Presence] in Urine

168

11.53

115.65

2.1

3.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1762

5465

1.91

115.39

4.2

2.5

30.70

32.15

6.04

1370

3976

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

277

282

5.62

114.53

1.8

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

176

10.13

112.88

3.2

2.3

40370.39

43616.16

ug/l

0.79

176

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

178

103

9.85

112.29

9.0

4.5

11.02

9.00

mg/l

3.59

167

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

410

617

3.82

109.99

2.4

1.2

7.18

6.91

g/l

1.90

385

574

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

548

1011

3.13

109.65

1.3

1.2

464.34

423.12

mg/l

1.26

525

966

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

409

617

3.81

109.37

2.4

1.2

3.53

3.59

g/l

0.45

386

574

(3010838) Calcium [Moles/time] in 24 hour Urine

411

623

3.79

109.21

2.2

2.0

5.31

5.72

mmol/24h

1.30

373

586

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

409

618

3.80

109.14

2.4

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

535

980

3.15

108.25

2.0

2.1

9.30

9.54

mg/l

0.35

505

945

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1931

6294

1.82

108.20

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1086

2879

2.20

107.52

2.4

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

470

802

3.37

105.92

2.9

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

501

895

3.22

105.39

1.4

1.2

1811.03

602.99

e6/l

0.47

412

736

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

501

896

3.22

105.21

1.4

1.2

28.14

10.26

e6/l

0.97

393

714

(3016244) Insulin [Units/volume] in Serum or Plasma

286

331

4.94

104.22

2.7

3.7

31.06

25.88

mu/l

0.86

272

308

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

144

12.61

103.71

1.7

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1389

4111

1.99

103.50

2.3

2.2

21.88

20.67

au/ml

0.16

108

552

(3017732) Neutrophils [#/volume] in Blood

1333

3887

2.01

103.46

2.7

1.6

4.64

4.42

e9/l

0.26

1163

3410

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

393

601

3.75

103.21

2.4

1.2

2.79

2.73

g/l

0.44

369

558

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

375

554

3.88

103.03

1.1

1.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

639

1350

2.74

101.47

1.3

22.85

32.13

u/ml

0.46

(3020911) Cortisol [Moles/time] in 24 hour Urine

145

11.79

101.03

1.5

1.3

107.47

85.38

nmol/24h

0.84

145

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

365

538

3.89

100.58

1.2

3.40

3.31

u/ml

0.08

176

234

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

487

886

3.16

99.57

1.2

1.1

3.74

3.45

mmol/l

7.76

457

838

(46235355) HIV 1 and 2 tests - Meaningful Use set

5523

23713

1.46

99.31

2.1

1.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

390

615

3.64

98.28

2.8

2.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

374

572

3.75

98.21

1.2

3.98

3.54

u/ml

0.09

131

195

(1617658) Protocol used for examination of sentinel lymph nodes

48.00

98.01

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

371

566

3.76

97.74

2.5

1.2

9.61

10.20

g/l

1.83

345

522

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1280

3757

2.00

97.38

1.3

46.09

49.32

au/ml

0.17

240

(3000012) Reticulocyte production index

181

134

7.70

97.26

1.9

1.3

—

(3037756) Immunofixation for Serum or Plasma

213

195

6.23

96.86

1.9

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

347

509

3.91

96.21

2.5

1.3

0.36

0.16

g/l

1.53

316

461

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

279

342

4.67

95.64

1.3

—

(3025941) Bacteria identified in Stool by Culture

1240

3626

2.00

95.25

1.3

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

158

101

8.91

93.80

1.7

1.4

5.04

1.47

nmol/l

1.47

134

(3030981) Hyaline casts [#/volume] in Urine by Automated count

799

1966

2.36

93.52

3.0

1.8

0.22

e6/l

0.01

777

1885

(3005322) IgE [Units/volume] in Serum or Plasma

1436

4474

1.88

91.82

1.4

1.3

231.69

248.29

u/ml

0.09

1330

4180

(3000034) Microalbumin [Mass/volume] in Urine

177

138

7.31

91.57

3.6

1.6

44.34

63.11

mg/l

0.38

136

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

583

1251

2.69

89.89

1.4

1.3

12.03

12.17

u/ml

0.01

198

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

280

364

4.40

89.88

1.9

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

280

365

4.39

89.60

1.9

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

112

15.91

89.34

39.7

28.1

7.75

6.43

ug/l

3.22

103

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

567

1203

2.72

89.26

1.3

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

577

1240

2.68

88.70

1.4

1.3

6.42

10.38

u/ml

0.44

131

(3013139) Helicobacter pylori Ag [Presence] in Stool

1218

3630

1.96

88.54

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

130

11.20

88.26

2.9

1.4

172.23

107.07

umol/l

0.66

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

520

1059

2.83

88.12

1.5

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4604

19434

1.46

88.09

1.8

1.7

—

(1002224) Polysomnography panel

1032

2903

2.07

87.72

1.1

1.0

—

(4200892) Spirometry reversibility

1063

3034

2.04

86.95

1.4

1.3

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

247

296

4.77

86.79

1.6

1.4

72.60

72.14

0.15

231

282

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

223

242

5.26

86.77

1.5

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

206

5.70

86.65

1.6

1.2

—

(3037121) Protein [Mass/volume] in Urine

541

1144

2.72

85.68

3.7

3.0

0.53

0.33

g/l

1.06

250

451

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

537

1132

2.73

85.53

1.3

1.2

259.39

226.65

u/ml

1.60

323

710

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

315

471

3.83

85.22

2.3

1.2

0.02

0.00

g/l

0.61

302

447

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

242

290

4.76

85.04

1.6

1.4

562.85

522.46

mu/l

0.11

226

276

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

242

291

4.75

84.73

1.4

1.2

20.32

14.38

u/l

0.53

218

252

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4837

20732

1.44

84.70

1.8

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

241

290

4.74

84.32

2.9

2.0

1.43

1.57

0.18

223

257

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

512

1060

2.78

84.26

1.5

1.2

13.94

22.09

u/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

270

360

4.29

84.18

1.6

1.2

—

(3016879) Cocaine [Presence] in Urine

1269

3906

1.90

83.87

2.3

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

443

846

3.01

83.76

1.4

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

240

291

4.71

83.29

1.1

95.23

92.80

0.56

226

265

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

301

451

3.82

81.22

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

516

1096

2.71

81.04

1.3

49.25

43.22

u/ml

0.27

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

264

358

4.21

80.69

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

365

631

3.31

80.67

2.4

2.0

132.33

136.29

g/l

2.47

286

476

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

339

559

3.47

80.27

3.3

2.8

189.73

17.44

u/ml

0.84

285

478

(40768795) Lymph node Pathology biopsy report

143

101

8.05

79.48

1.2

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

345

580

3.41

79.45

1.3

1.2

42.86

56.00

titre

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

301

466

3.69

77.79

2.4

1.2

38.31

40.28

g/l

4.60

277

422

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

281

415

3.87

77.27

2.4

1.2

0.00

g/l

0.08

268

392

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

293

447

3.75

77.22

1.4

1.2

5.87

6.28

umol/l

0.89

276

421

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

279

410

3.89

77.21

2.4

1.2

0.00

g/l

-0.00

268

391

(43055514) Macroprolactin [Presence] in Serum or Plasma

206

233

5.04

76.93

1.5

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

141

103

7.79

76.55

1.4

1.2

133.60

131.19

nmol/l

0.20

141

103

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

479

1014

2.71

75.68

1.5

1.2

99.37

107.06

u/ml

0.58

103

218

(3002079) Sodium [Moles/time] in 24 hour Urine

134

8.19

75.39

1.2

1.3

161.17

145.37

mmol/24h

0.90

134

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

620

1498

2.39

75.33

2.1

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

172

167

5.86

74.36

2.6

1.58

1.47

g/24h

0.13

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

230

300

4.37

73.60

1.6

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

377

706

3.06

73.60

1.5

1.6

0.65

0.75

g/l

1.35

273

555

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

259

376

3.93

72.82

2.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

411

818

2.88

72.48

1.4

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

449

941

2.74

72.26

1.3

2.86

7.61

u/ml

0.68

(3042111) Morphology [Interpretation] in Bone marrow Narrative

178

186

5.45

71.90

1.6

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

398

782

2.92

71.75

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

432

890

2.79

71.70

1.6

1.4

6.60

11.74

iu/ml

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

561

1325

2.44

71.50

1.9

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

1339

4417

1.77

70.69

2.3

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

433

903

2.75

70.31

1.3

1.2

11.03

15.16

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

960

2848

1.96

70.30

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

667

1719

2.24

70.12

2.3

2.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

253

372

3.88

70.00

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

882

2549

2.00

69.45

1.4

1.2

—

(3042733) HLA Ab [Presence] in Serum

19.14

69.16

5.2

2.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

212

272

4.44

69.15

1.5

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1347

4487

1.75

68.73

2.3

1.3

—

(3027008) Opiates [Presence] in Urine

1345

4479

1.75

68.70

2.2

1.2

—

(3024471) HLA-A [Type]

18.38

68.20

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

151

140

6.14

68.02

2.0

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

151

140

6.14

68.02

2.0

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

151

140

6.14

68.02

2.0

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

174

190

5.21

67.36

1.5

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

194

239

4.62

66.24

1.9

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

194

240

4.60

65.93

3.6

2.7

299.72

14.14

u/ml

1.42

181

219

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

428

921

2.66

65.60

3.3

3.4

56.58

56.03

0.39

428

921

(3024932) HLA-DR beta [Type]

18.99

65.57

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1077

3408

1.84

64.93

2.0

1.7

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

422

910

2.66

64.42

3.1

3.3

3.89

3.75

e9/l

0.72

422

910

(3016038) Potassium [Moles/volume] in Urine

105

9.17

63.68

2.4

1.5

33.16

37.33

mmol/l

0.52

(3008757) Leukocyte morphology finding [Identifier] in Blood

175

205

4.86

63.09

3.7

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

184

226

4.64

63.05

1.2

60.68

60.74

u/l

0.00

167

205

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3714

15862

1.41

62.88

2.2

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3275

13710

1.43

61.87

3.9

2.7

1.51

1.64

ug/l

2.25

2974

12888

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

103

8.86

61.14

1.2

1.0

—

(3027944) Amphetamines [Presence] in Urine

1310

4472

1.71

61.08

2.3

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

254

416

3.48

60.80

1.4

1.3

0.37

0.41

g/l

0.81

167

299

(3027135) IgG subclass 1 [Mass/volume] in Serum

254

417

3.48

60.59

1.4

1.3

6.95

6.61

g/l

0.64

166

297

(3028192) IgG subclass 2 [Mass/volume] in Serum

254

417

3.48

60.59

1.4

1.3

2.90

3.15

g/l

1.18

167

296

(4062490) Immunoglobulin typing, IgG

252

417

3.45

59.45

1.5

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

110

7.71

59.44

2.7

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

358

742

2.76

58.81

1.1

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

13.18

58.24

1.9

1.1

177.17

4.30

ug/min

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

755

2203

1.98

57.77

1.1

5.29

6.94

u/ml

0.40

109

405

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

740

2144

1.99

57.74

1.6

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

164

198

4.71

57.29

2.0

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

193

269

4.09

57.17

1.4

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1244

4270

1.69

56.73

1.1

1.0

—

(40768446) Kidney Pathology biopsy report

100

8.23

56.55

1.8

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

568

1499

2.18

56.38

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

207

309

3.82

56.24

1.1

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

266

474

3.20

56.23

1.3

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

266

475

3.20

56.05

1.3

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

157

186

4.80

55.97

1.7

1.4

5.21

5.12

u/l

0.08

127

168

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4041

17793

1.37

55.95

2.3

2.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

176

232

4.32

55.73

1.5

1.2

1.31

1.59

promille

1.07

135

182

(40768793) Breast Pathology biopsy report

299

578

2.95

55.46

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

350

747

2.68

54.50

2.1

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

567

1518

2.15

54.34

1.2

1.1

—

(3011648) Oxygen content in Venous blood

122

115

6.03

54.24

4.7

2.2

10.99

12.61

2.76

122

115

(42529406) Shigella sp [Presence] in Stool by Culture

569

1532

2.13

53.77

1.2

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

190

275

3.93

53.72

1.7

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

190

276

3.92

53.48

1.7

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

199

310

3.66

51.13

7.8

1.6

7.63

5.73

mmol/l

7.64

174

238

(3003434) Protein [Mass/volume] in Pleural fluid

7.20

50.94

1.7

1.4

33.67

42.42

g/l

4.89

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

186

277

3.82

50.73

1.1

1.2

1.06

1.05

ratio

0.20

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

116

112

5.88

50.51

1.5

1.2

—

(40768443) Skin Pathology biopsy report

672

1981

1.95

49.90

1.2

1.1

—

(3011412) CD3 cells [#/volume] in Blood

208

344

3.44

49.18

2.4

2.3

1.29

1.34

e9/l

0.35

180

295

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

186

284

3.73

49.11

1.2

1.1

1.89

1.69

mmol/l

2.04

171

269

(3022689) Creatine [Moles/volume] in Urine

10.37

48.99

1.7

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

188

291

3.68

48.74

1.1

1.0

294.79

283.79

mg/l

0.78

161

271

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

726

2217

1.89

48.63

1.3

1.2

3.43

3.49

ug/l

0.08

682

2125

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

868

2810

1.78

48.36

2.5

1.6

30.94

23.96

u/ml

1.45

836

2717

(3004451) EKG impression Narrative

17.29

47.82

1.2

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

6.80

47.74

1.6

1.3

1990.15

4996.81

e6/l

1.89

(40768441) Liver Pathology biopsy report

144

184

4.45

47.32

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

288

600

2.74

46.94

1.4

1.3

51.35

22.02

u/ml

1.10

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.84

46.50

1.4

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

6.84

46.50

23.1

14.6

119.08

120.70

ug/l

0.06

(3030313) Adrenal Ab [Titer] in Serum

7.45

46.48

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.94

46.44

2.7

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

377

907

2.38

46.24

1.1

1.0

—

(3017704) Immunofixation for Urine

8.98

45.58

1.7

1.5

—

(3045142) Bone marrow Pathology biopsy report

119

132

5.12

45.48

1.4

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

143

189

4.30

45.22

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

7.26

45.07

1.4

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

256

513

2.85

44.73

1.3

—

(3023419) Bacteria identified in Sputum by Culture

188

310

3.45

44.68

2.8

2.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

195

330

3.36

44.64

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

161

238

3.85

44.39

2.2

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

16.99

44.24

1.9

1.0

—

(3042517) Benzodiazepines panel - Urine

41.59

43.87

3.8

2.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

746

2387

1.80

43.14

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

6.28

42.96

1.7

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

7.11

42.87

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

230

444

2.95

42.86

1.3

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

10.52

42.84

1.8

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

20.91

42.17

7.1

1.0

—

(21494755) Public health laboratory ask at order entry panel

2095

15830

0.71

41.64

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

216

409

3.01

41.57

1.3

1.5

—

titre

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3764

17019

1.32

41.57

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

136

186

4.15

41.34

3.2

1.8

—

(3045414) Leukocytes [Presence] in Urine

719

2307

1.79

41.19

1.8

1.5

—

(3008898) HLA-B27 [Presence]

913

3147

1.67

40.70

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

135

187

4.10

40.42

2.9

2.2

57.20

54.32

0.76

120

159

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

132

180

4.17

40.28

1.1

96.86

92.69

0.60

103

132

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

20.03

39.87

5.9

5.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

124

162

4.35

39.80

1.9

2.0

2.06

1.84

umol/l

1.71

117

155

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

149

226

3.75

39.77

1.2

20.00

6.39

u/ml

0.51

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.80

39.67

2.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

315

749

2.40

39.66

1.4

1.2

—

(3019977) pH of Arterial blood

7.30

39.61

3.3

1.5

7.42

7.44

0.72

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

139

201

3.93

39.47

1.1

1.81

6.04

nmol/l

0.63

(3003338) MCHC [Mass/volume]

13683

72505

1.29

39.44

17.9

5.9

333.13

334.08

g/l

28.45

13607

71757

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.73

39.28

2.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

6.55

39.26

1.6

1.3

13421.98

62398.83

e6/l

0.83

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

115

143

4.57

39.03

1.6

1.5

7.80

6.26

u/l

0.50

125

(3023410) Appearance of Cerebral spinal fluid

223

449

2.83

38.71

1.6

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

212

417

2.89

38.32

1.5

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

212

417

2.89

38.32

1.5

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

212

417

2.89

38.32

1.5

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

102

117

4.95

37.75

1.2

109.78

67.24

u/l

1.58

110

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

218

440

2.82

37.69

1.5

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

136

201

3.84

37.58

1.8

94.84

103.16

1.61

122

179

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

212

423

2.85

37.40

1.6

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

256

566

2.58

37.40

1.1

1.50

1.38

g/l

4.59

226

522

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

101

116

4.94

37.33

1.2

41.04

10.15

u/l

1.43

108

(40768806) Pleura Pathology biopsy report

6.61

37.18

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

212

427

2.83

36.80

1.5

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

139

213

3.71

36.64

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

787

2684

1.69

36.46

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

8.06

35.82

3.1

2.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

123

175

3.99

35.69

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

6.55

35.49

1.6

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.26

35.48

1.4

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

173

316

3.11

35.36

1.1

—

(21494434) Karyotype in Bone marrow

104

5.07

35.34

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2445

10597

1.35

35.34

2.0

1.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

121

172

3.99

35.15

2.8

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

169

4.00

34.62

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

558

1759

1.82

33.85

1.3

—

(3012441) Differential panel - Pleural fluid

6.17

33.76

1.7

1.4

—

(3047189) Immunofixation for 24 hour Urine

9.56

33.72

2.2

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

157

278

3.21

33.70

2.4

2.3

0.20

0.24

e9/l

1.49

129

230

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

112

4.76

33.48

1.2

31.86

12.06

u/l

1.67

(3044927) Protein electrophoresis panel - Urine

102

131

4.42

33.45

1.4

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

182

358

2.89

32.96

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

182

358

2.89

32.96

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

182

359

2.88

32.81

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

180

353

2.90

32.77

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

5.08

32.77

1.4

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

117

4.61

32.66

1.2

89.94

74.59

u/l

0.71

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

162

3.96

32.52

1.1

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

179

352

2.89

32.44

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

157

285

3.13

32.44

2.4

2.3

518.22

510.84

e6/l

0.06

127

231

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

35.36

32.43

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

179

353

2.88

32.29

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

102

4.89

32.27

3.2

3.0

28.57

27.41

umol/l

0.31

(40757494) Bilirubin.total [Moles/volume] in Blood

5.82

32.13

2.7

2.8

16.90

45.93

umol/l

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

131

212

3.51

32.11

1.3

1.1

69.87

94.18

1.80

(3034426) Prothrombin time (PT)

5.11

31.86

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

222

498

2.54

31.60

1.2

1.1

37.71

40.86

mg/l

0.43

186

409

(3000330) Specific gravity of Urine by Test strip

593

1947

1.75

31.44

3.0

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

6.45

31.28

1.5

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

6.45

31.28

1.5

1.8

—

(3042631) Mycobacterium sp identified in Specimen

136

231

3.34

31.11

2.6

3.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

13.21

31.05

1.9

1.1

179417.34

1323081.00

nmol/l

0.82

(1761482) Bacteria [#/volume] in Urine by Culture

282

714

2.25

31.00

3.2

2.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

221

505

2.49

30.33

1.1

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

49.83

30.28

7.6

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

155

292

3.02

30.22

1.1

—

(3006270) Folate [Moles/volume] in Blood

155

292

3.02

30.22

1.1

398.69

401.17

nmol/l

0.05

142

280

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1936

8280

1.36

30.13

1.9

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

211

473

2.54

30.10

1.1

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

8.85

29.80

1.7

1.5

149.91

42.59

mu/l

1.68

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

155

296

2.97

29.56

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

175

360

2.76

29.36

1.1

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

245

598

2.33

29.28

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

212

486

2.48

28.93

1.1

1.0

231.08

220.00

mg/l

0.34

184

431

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

155

300

2.93

28.92

1.3

1.2

—

(3000492) Spirometry study

1739

7363

1.37

28.75

1.4

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

47.56

28.73

7.8

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

9.80

28.54

1.2

1.0

2.62

—

pmol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

112

177

3.59

28.42

1.7

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

584

1965

1.70

28.42

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

113

182

3.52

27.94

1.7

1.5

1039140.00

368883.12

iu/ml

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

9.43

27.92

1.6

4.2

2.00

1.22

mmol/l

0.54

(3017569) Oxygen content in Arterial blood

7.55

27.86

1.8

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

112

4.35

27.83

1.4

1.2

5.94

5.11

mmol/l

2.93

102

(3051651) Icteric interference index of Serum or Plasma

122

4.18

27.79

4.0

2.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

176

376

2.66

27.58

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

175

375

2.65

27.28

1.2

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

148

289

2.91

27.23

1.2

15.46

7.60

u/ml

0.35

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

5.58

27.20

2.6

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

5.58

27.20

2.6

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

10.55

27.11

4.1

4.2

51.21

13.00

ug/min

3.18

(1761868) Lipid panel - Serum or Plasma

6565

32876

1.20

27.01

2.8

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

102

157

3.68

26.85

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

10.78

26.76

2.4

1.7

1184.78

1564.15

e6/l

0.11

(3045424) Erythrocytes [Presence] in Urine

311

871

2.03

26.71

1.5

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.71

26.65

1.3

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

344

1001

1.96

26.61

1.5

1.4

—

(40765096) Chromosome analysis panel by Banding

9.36

26.56

1.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

149

299

2.83

26.18

1.2

32.00

64.15

u/ml

0.75

(3051611) Lipemic interference index of Serum or Plasma

133

250

3.02

26.09

3.5

1.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

631

2218

1.63

26.05

1.4

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

150

304

2.80

25.91

1.2

49.92

22.77

u/ml

0.55

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

149

301

2.81

25.88

1.2

55.67

31.85

u/ml

0.45

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

180

403

2.54

25.81

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

108

4.25

25.54

13.7

1.2

2388.38

14770.98

mg/l

1.15

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

5.12

25.46

1.5

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

5.12

25.46

1.5

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

5.12

25.46

2.5

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

607

2129

1.63

25.29

1.6

28.34

0.51

iu/ml

0.49

117

404

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

161

344

2.66

25.27

1.3

178.92

223.45

titre

0.25

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

161

344

2.66

25.27

1.3

120.00

276.36

titre

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

7.11

25.15

4.0

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

7.11

25.15

4.0

1.7

—

(3035880) pH of Pleural fluid

7.96

25.05

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

102

166

3.48

24.91

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

932

3616

1.48

24.90

1.8

1.3

4.04

3.18

mg/l

2.03

737

2137

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

131

3.85

24.87

1.0

44.51

47.06

ng/l

0.13

101

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

8.39

24.80

1.4

1.3

349.97

266.43

pmol/l

1.04

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

132

3.82

24.64

1.0

882.90

701.98

ng/l

1.97

100

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

132

3.82

24.64

1.0

310.80

337.91

ng/l

0.27

104

(40768800) Prostate Pathology biopsy report

127

242

2.98

24.40

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.76

24.33

1.8

1.2

3239.50

2671.00

u/ml

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

354

1075

1.88

24.22

1.8

2.0

13.40

8.14

titre

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12792

68367

1.21

24.18

3.8

3.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

9.77

24.09

1.2

1.4

38.79

37.83

ng/l

0.02

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

136

272

2.84

24.08

1.5

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

160

3.44

23.27

2.5

2.6

52.17

50.70

umol/l

0.16

154

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

10.42

23.01

2.1

1.5

2931.84

20331.50

e6/l

—

(3028717) Thiamine [Mass/volume] in Blood

10.42

23.01

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1187

4890

1.40

22.97

1.4

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2478

11361

1.27

22.90

3.6

2.6

22.48

22.50

0.02

905

3898

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

282

810

1.98

22.69

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

306

905

1.93

22.66

1.7

9327.50

10366.41

e6/l

0.24

239

678

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

109

200

3.09

22.30

1.2

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

8.60

22.29

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.38

22.24

1.1

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

22.22

7.7

0.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

22.22

1.6

0.0

509.34

—

nmol/l

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

9.26

22.11

1.7

1.2

13.00

10.63

g/l

0.36

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

161

3.35

21.95

1.4

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

149

331

2.56

21.78

1.1

1.04

1.01

u/l

0.32

128

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

181

442

2.33

21.74

1.3

1.44

3.46

u/ml

1.98

249

(3019832) Treponema pallidum Ab [Presence] in Serum

3598

17299

1.22

21.48

1.8

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.99

21.31

1.7

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

6.20

21.20

1.5

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1806

12781

0.78

21.09

1.7

1.5

—

(3044007) Cell count panel - Peritoneal fluid

10.96

20.94

1.8

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

156

3.31

20.70

1.2

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

134

3.51

20.58

2.0

2.2

202.71

222.92

e6/l

0.18

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

170

414

2.33

20.57

2.0

1.5

25.79

27.84

mg/l

0.16

107

(3022621) pH of Urine by Test strip

903

3617

1.43

20.44

2.8

2.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

113

224

2.86

20.39

1.8

2.0

129.06

107.50

2.44

108

215

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

424

1435

1.69

20.29

1.6

1.4

84.34

45.12

pmol/l

3.46

407

1394

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

159

3.24

20.13

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.51

20.02

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

222

612

2.06

20.00

1.8

1.6

24.75

28.04

iu/ml

0.14

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

3.69

19.96

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.24

19.81

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

101

192

2.98

19.58

1.1

1.2

0.30

0.29

g/l

0.60

153

(4034850) Laboratory test

482

1703

1.62

19.57

10.6

4.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

271

812

1.90

19.39

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

295

910

1.84

19.33

2.5

2.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

182

3.02

19.22

1.3

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

361

1191

1.73

18.97

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

128

284

2.56

18.83

1.5

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

103

203

2.88

18.81

2.5

2.9

44.48

43.12

0.26

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.22

18.56

1.3

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

12.85

18.25

1.1

1.0

—

mmol/l

—

(44813793) Dust mix specific IgE antibody measurement

183

487

2.13

18.08

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

8.93

18.04

2.5

1.6

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

113

3.56

18.01

1.3

1.1

10.30

4.55

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

125

3.40

17.83

1.2

1.3

68.75

147.69

titre

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

4.37

17.70

1.0

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

180

2.93

17.55

1.1

1.2

109.20

107.06

0.26

159

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

4.05

17.43

1.5

1.1

121.13

108.45

nmol/l

0.25

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

191

529

2.05

17.08

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

404

1417

1.62

16.95

1.1

3.15

3.42

u/ml

0.15

213

872

(21494814) CD8 cells/100 lymphocytes in Specimen

121

3.37

16.94

2.0

—

(3014271) Vancomycin [Susceptibility]

4.75

16.91

2.3

1.9

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

285

910

1.78

16.79

1.7

1.8

5360.00

3646.22

titre

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

22.62

16.69

1.1

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.67

16.60

1.4

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1241

8952

0.77

16.58

1.4

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

545

2063

1.51

16.46

2.1

2.4

5.43

5.28

umol/l

0.14

390

1527

(3021788) Differential panel - Synovial fluid

243

747

1.85

16.18

1.6

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

202

2.72

16.15

3.5

4.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

4.72

16.08

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

107

238

2.55

15.75

2.0

1.3

186.64

183.68

u/l

0.30

107

238

(3005082) Progesterone [Moles/volume] in Serum or Plasma

300

994

1.72

15.61

1.4

1.3

28.86

34.47

nmol/l

2.75

272

949

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

142

363

2.22

15.53

1.7

1.5

41.19

41.56

0.03

244

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

461

1705

1.54

15.51

1.5

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

130

320

2.30

15.50

1.5

1.7

8.80

8.36

ug/l

0.05

116

287

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

120

3.26

15.47

1.8

1.6

0.17

0.31

nmol/l

1.22

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

872

3645

1.37

15.44

1.4

—

(3001556) Androgen free Index in Serum or Plasma

112

3.34

15.35

1.4

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

157

2.92

15.31

1.4

12.18

20.46

u/ml

1.25

(3024891) Influenza virus A+B Ag [Presence] in Specimen

483

1813

1.52

15.20

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.73

15.20

2.3

2.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

362

1271

1.62

15.17

1.2

1.1

16.52

12.01

au/ml

0.38

106

(3028433) Virus identified in Specimen by Culture

116

3.27

15.13

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

155

2.92

15.13

1.2

1.1

105.31

113.20

0.70

139

(3001186) Copper [Moles/volume] in Serum or Plasma

3.57

14.85

1.5

1.3

17.94

16.38

umol/l

0.75

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

152

2.91

14.63

1.1

90.53

96.10

0.67

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

6.53

14.49

2.5

2.0

66.03

43.76

pmol/l

0.50

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

160

2.83

14.36

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

110

262

2.38

14.13

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.84

14.08

2.4

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.28

14.05

1.3

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

13.99

1.2

0.0

52.53

—

nmol/l

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

938

4030

1.33

13.91

1.3

242.45

234.54

miu/ml

0.26

456

2139

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

7.85

13.84

1.0

1.2

61.42

34.38

mg/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.55

13.78

1.1

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

147

2.85

13.47

1.2

1.1

91.13

99.54

0.82

(3009871) Measles virus Ab [Titer] in Serum

216

2.49

13.46

1.9

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.47

13.36

2.4

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.61

13.30

1.1

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

6.33

13.21

3.1

1.2

6.53

5.58

mmol/l

0.65

(3045683) HLA typing for celiac disease panel - Blood or Tissue

177

528

1.90

13.01

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

6.68

12.81

1.8

1.3

22.94

20.61

g/l

0.17

(3048879) Bone marrow aspiration report

6.68

12.81

2.4

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

6.09

12.79

1.1

0.69

0.73

umol/24h

0.14

(3035320) C reactive protein [Mass/volume] in Body fluid

128

341

2.13

12.77

2.9

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

334

1203

1.58

12.69

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

118

3.02

12.67

1.5

1.7

9.28

8.13

ug/l

1.17

118

(3044941) Cell count panel - Synovial fluid

188

581

1.84

12.44

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

245

820

1.70

12.41

1.1

—

2.28

—

(3029075) Extractable nuclear Ab panel - Serum

123

2.95

12.35

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

326

1177

1.57

12.28

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

4.79

12.05

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

7.22

12.02

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.13

11.95

2.0

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.32

11.86

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.18

11.81

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

799

3438

1.33

11.76

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

138

392

2.00

11.70

1.1

1.0

1573.38

1366.83

miu/ml

1.18

138

392

(3021367) Citalopram [Moles/volume] in Serum or Plasma

+∞

11.52

1.3

0.0

123.25

—

nmol/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

18.83

11.50

1.1

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

195

2.44

11.48

1.2

1.1

310.13

369.32

u/l

0.15

187

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.12

11.45

1.1

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

14.84

11.19

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

314

1153

1.55

11.05

1.1

—

(3020491) Glucose [Moles/volume] in Blood

148

441

1.90

11.00

1.8

1.3

6.31

5.21

mmol/l

4.05

104

356

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

162

2.55

10.94

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

166

516

1.82

10.85

1.8

1.6

46.71

47.51

0.08

100

363

(3014051) Protein [Presence] in Urine by Test strip

345

1301

1.51

10.76

2.3

1.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1785

8531

1.20

10.71

2.6

2.1

0.62

0.68

ug/l

2.15

1021

3833

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

132

2.70

10.53

3.1

2.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

169

537

1.78

10.32

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.60

10.26

1.3

1.2

36.22

155.60

ug/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

225

2.24

10.16

1.2

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

109

2.86

10.15

1.1

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

243

860

1.60

10.04

1.6

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.43

9.94

1.5

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

6.65

9.83

1.3

1.0

—

(3024263) Appearance of Synovial fluid

180

2.36

9.63

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

4.08

9.53

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

4.40

9.39

1.8

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.95

9.22

4.4

4.7

—

(4281824) Cell count and differential, peritoneal fluid

122

363

1.90

9.19

1.2

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.85

9.18

1.4

114.26

76.30

ng/l

0.84

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

175

2.33

9.03

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.36

8.98

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

326

1265

1.46

8.93

1.1

—

(3019174) dRVVT (LA screen)

3.95

8.88

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

243

2.10

8.84

1.1

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

240

2.10

8.77

1.6

1.5

2.56

3.11

u/field

0.21

171

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

175

2.30

8.65

1.1

156.33

293.20

ng/l

0.36

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

9.77

8.63

2.7

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

10.18

8.36

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

120

2.55

8.18

1.5

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

379

1543

1.40

8.05

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.94

8.01

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.94

8.01

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.94

8.01

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.94

8.01

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

3.02

7.99

1.2

1.1

—

(3007463) Buprenorphine [Presence] in Urine

15.82

7.78

3.9

4.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

148

494

1.70

7.76

1.4

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.24

7.76

2.5

1.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

116

361

1.82

7.70

1.4

112558.21

41227.85

e6/l

0.56

243

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

112

2.53

7.49

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

+∞

7.40

5.2

0.0

536.44

—

umol/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

151

514

1.66

7.40

1.1

7.31

7.33

iu/ml

0.00

147

(3026726) Creatinine [Moles/volume] in Specimen

8.74

7.39

3.3

1.3

570.53

862.91

umol/l

0.29

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

103

313

1.86

7.38

1.8

1.6

2.29

2.20

u/field

0.05

152

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

113

2.50

7.36

1.2

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.23

7.29

1.1

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

109

339

1.82

7.28

1.1

5.92

14.18

u/ml

2.18

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.62

7.26

1.3

40.22

52.16

1.06

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.52

7.20

1.0

—

(3017509) Phencyclidine [Presence] in Urine

2.73

7.11

2.0

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

8.01

7.07

2.9

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.88

7.00

1.1

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.73

6.93

1.2

1.1

76.92

99.31

0.70

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

9.42

6.82

2.6

4.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.77

6.77

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.39

6.62

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.79

6.52

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.63

6.35

1.2

1.1

65.09

95.14

0.92

(3032352) Blasts [#/volume] in Cerebral spinal fluid

10.50

6.26

4.5

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.79

6.20

2.6

4.3

—

(3025577) Chromium [Mass/volume] in Blood

149

2.16

6.19

2.0

2.1

2.58

2.66

ug/l

0.04

131

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

430

0.41

6.11

6.0

7.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

430

0.41

6.11

3.0

3.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

541

2422

1.27

6.09

1.1

2.23

2.72

u/ml

0.50

264

1264

(3026470) Cobalt [Mass/volume] in Blood

154

2.13

6.07

1.9

2.1

2.43

2.81

ug/l

0.27

145

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

3.27

6.07

1.6

1.5

1.40

1.69

ug/l

0.61

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

6.01

5.98

4.8

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

303

1254

1.37

5.96

3.6

2.3

23.76

26.30

mg/l

0.63

184

749

(3025018) Bordetella pertussis Ab [Titer] in Serum

137

483

1.61

5.95

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

167

2.07

5.93

1.2

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.06

5.89

1.6

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

199

1.96

5.85

1.8

1.4

5.92

4.92

0.14

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

168

2.05

5.84

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

168

2.05

5.84

1.2

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.55

5.78

1.1

44.42

80.13

1.85

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

339

1436

1.34

5.76

1.4

1.5

7.08

6.14

mmol/l

6.80

311

1291

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

+∞

5.76

1.0

0.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.76

1.3

0.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

12.43

5.73

1.0

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

4.37

5.72

1.5

1.1

1.36

5.45

ml/s/173m2

0.54

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

695

4735

0.82

5.62

1.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

120

2.22

5.44

1.3

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.83

5.42

1.6

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.31

5.31

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

100

2.32

5.26

1.0

0.01

0.13

u/ml

0.55

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.46

5.17

2.7

2.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

127

2.14

5.13

2.7

1.4

106.11

95.83

ng/l

0.17

(3003888) Timothy IgE Ab [Units/volume] in Serum

483

2183

1.26

5.09

1.1

6.26

6.40

u/ml

0.05

261

1249

(3002523) Influenza virus A Ag [Presence] in Specimen

422

1877

1.28

5.08

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

11.30

5.07

1.6

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.83

5.07

1.6

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.11

5.05

2.3

2.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.11

5.05

1.0

23.88

10.55

u/l

0.36

(3013293) Extractable nuclear Ab [Presence] in Serum

2.44

5.03

2.1

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

132

2.10

5.02

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.10

5.00

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

7.53

4.99

1.3

1.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.73

4.95

1.8

1.6

1.00

1.77

mg/l

0.63

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

129

2.10

4.95

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

421

1879

1.27

4.94

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

4.94

1.0

0.0

—

(3008717) Parietal cell Ab [Titer] in Serum

+∞

4.94

1.2

0.0

1411.67

—

titre

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

+∞

4.94

2.3

0.0

210.67

—

nmol/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

141

526

1.52

4.89

1.2

—

(3013466) aPTT in Blood by Coagulation assay

3.46

4.85

1.1

36.03

35.91

0.03

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

6.12

4.76

1.5

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

162

627

1.46

4.72

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.50

4.69

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

233

1768

0.74

4.69

1.6

1.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.23

4.64

1.8

1.2

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.68

4.64

1.8

1.5

1.13

4.05

mg/l

2.07

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.68

4.64

1.8

1.5

0.71

3.75

mg/l

2.60

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.68

4.64

1.8

1.5

2.04

2.00

mg/l

0.01

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.68

4.64

1.8

1.5

1.26

1.47

mg/l

0.11

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.68

4.64

1.8

1.5

0.49

1.27

mg/l

1.28

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.68

4.64

1.8

1.5

0.80

2.13

mg/l

1.22

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.68

4.64

1.8

1.5

0.41

1.22

mg/l

1.06

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.68

4.64

1.8

1.5

2.43

5.93

mg/l

1.67

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.68

4.64

1.8

1.5

1.10

3.74

mg/l

1.72

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.44

4.63

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

5.27

4.61

1.1

1.2

1.35

2.77

mmol/l

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

457

2081

1.25

4.56

1.1

1.00

1.20

u/ml

0.29

199

967

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2691

14002

1.10

4.56

1.5

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.49

4.52

1.2

1.1

0.77

36.43

mg/l

0.49

(4212803) Bone marrow aspirate examination

10.17

4.42

1.0

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.91

4.40

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.06

4.29

1.2

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.37

4.23

1.3

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.65

4.22

1.8

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.65

4.20

1.1

1.54

1.26

umol/24h

0.63

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

+∞

4.11

1.0

0.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.66

4.10

1.1

1.3

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.48

4.08

3.3

7.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

152

1.90

4.06

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

119

2.00

3.86

1.0

—

(40758292) HTLV I+II Ab panel - Serum

2.25

3.81

1.5

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.90

3.78

1.1

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.14

3.65

1.6

1.2

37.64

42.87

g/l

1.06

(3025130) Human papilloma virus identified in Specimen

342

1551

1.25

3.63

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

195

821

1.35

3.62

1.4

1.3

301.83

198.68

pmol/l

0.36

195

821

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.91

3.60

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

128

1.90

3.48

2.8

2.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.83

3.45

1.2

1.0

—

(3022475) Manganese [Moles/volume] in Blood

3.50

3.40

1.5

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

306

1.55

3.37

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

183

774

1.34

3.33

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.16

3.28

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.99

3.25

4.7

2.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

6.46

3.21

6.3

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.16

3.20

1.0

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

7.91

3.17

1.0

—

(3020650) Glucose [Presence] in Urine

209

1.65

3.15

1.4

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.51

3.13

2.1

1.6

—

(40757373) Influenza virus identified in Isolate

2.51

3.13

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.51

3.13

1.6

1.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.09

3.07

1.8

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

138

568

1.38

3.02

1.3

1.5

5.43

4.96

mmol/l

4.76

125

548

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.21

3.01

1.1

1.4

27.87

46.41

mg/l

1.28

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.35

2.99

1.3

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.67

2.98

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

5.65

2.97

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

177

761

1.32

2.93

1.1

0.63

5.13

u/ml

1.34

247

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

6.59

2.89

1.4

1.5

65.03

67.67

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

366

1718

1.21

2.89

1.1

6.42

5.50

u/ml

0.20

146

759

(40765089) Chromosome analysis panel - Blood by G-banded

124

506

1.39

2.88

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

449

2148

1.19

2.88

1.1

1.83

2.60

u/ml

0.80

221

1086

(3052592) Norovirus Ag [Presence] in Stool

2.60

2.85

1.5

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

102

403

1.43

2.84

1.8

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

389

1843

1.20

2.79

1.1

3.58

5.23

u/ml

1.23

187

929

(3040893) Potassium [Moles/volume] in Capillary blood

5.02

2.75

4.3

3.4

4.35

4.29

mmol/l

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

214

1.59

2.70

1.1

0.39

6.07

u/ml

0.81

192

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

132

1.76

2.69

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.23

2.67

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.23

2.67

1.1

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.08

2.66

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.93

2.53

9.8

2.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.53

2.51

1.0

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.02

2.47

1.0

1.1

0.39

1.70

u/ml

0.46

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.94

2.44

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.64

2.43

1.2

1.3

7.22

7.30

mmol/l

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

174

769

1.28

2.42

1.0

1.1

3.38

7.14

u/ml

0.43

197

(3015183) Erythrocyte sedimentation rate

124

523

1.34

2.41

1.1

—

(3006462) Nitrate [Presence] in Urine

276

1.48

2.39

2.7

2.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.11

2.38

3.0

2.7

42.13

47.27

umol/l

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.63

2.37

1.3

1.0

36.51

35.65

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.83

2.34

1.2

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.13

2.28

1.7

1.5

—

(3001729) Color of Synovial fluid

2.96

2.27

1.4

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.62

2.25

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

337

1.41

2.23

1.2

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.39

2.22

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.71

2.20

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

473

3052

0.87

2.18

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.47

2.18

1.0

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

311

1.42

2.15

1.1

4.27

22.39

u/ml

0.93

205

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

4.84

2.12

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

4.84

2.12

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

4.84

2.12

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

4.84

2.12

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.84

2.12

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

4.84

2.12

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

4.84

2.12

2.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

311

1489

1.18

2.08

1.1

1.0

0.59

0.46

u/ml

0.11

352

(3049233) Organic acids panel - Urine

3.95

2.08

1.0

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.48

2.07

1.0

1.1

326.50

254.38

u/l

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.18

2.06

1.4

1.1

—

(3005033) Fetal Nuchal fold Thickness US

777

4843

0.90

2.03

1.4

1.5

—

(3029612) Listeria sp Ab [Titer] in Serum

2.45

2.00

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

781

4856

0.90

1.95

1.4

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.23

1.94

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

161

728

1.25

1.93

1.0

0.32

1.14

u/ml

1.01

167

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

2.82

1.85

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.26

1.84

1.1

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.17

1.82

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.83

1.80

1.0

—

(3018291) Platelet Ab [Presence] in Serum

4.71

1.79

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

800

4938

0.91

1.75

1.5

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.78

1.75

1.0

0.12

1.08

u/ml

2.86

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.20

1.74

1.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

147

668

1.24

1.73

1.6

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

103

1.65

1.67

1.4

44.14

42.91

0.06

(3033942) Copper [Moles/time] in 24 hour Urine

2.57

1.67

1.4

1.0

2.88

0.30

umol/24h

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.66

1.65

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.83

1.65

4.1

1.5

16.08

3.06

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

369

1.32

1.60

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

248

1.39

1.59

2.4

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

128

579

1.25

1.59

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

265

1.37

1.52

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.79

1.51

1.1

1.2

—

(3016135) IgD [Mass/volume] in Serum

3.08

1.49

1.2

26.98

70.84

mg/l

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

125

1.54

1.48

1.0

1.1

0.04

1.01

u/ml

0.94

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

125

1.54

1.48

1.1

0.07

0.81

u/ml

0.80

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

176

1.45

1.47

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.53

1.46

1.0

1.80

2.75

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

145

673

1.22

1.45

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

230

1.38

1.41

1.1

1.27

13.84

u/ml

2.02

166

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.82

1.37

1.2

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

369

1.29

1.36

1.1

1.0

12.46

13.62

u/ml

0.12

234

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

3.14

1.33

2.8

2.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.14

1.33

1.2

1.0

—

(3000285) Sodium [Moles/volume] in Blood

2.14

1.32

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.65

1.32

1.1

—

(40762814) Titanium [Mass/volume] in Blood

1.88

1.32

2.3

2.6

3.42

8.28

ug/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.93

1.31

1.1

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.93

1.31

1.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

124

574

1.22

1.31

1.2

1.3

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.38

1.28

1.0

1.1

—

2.20

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.78

1.27

1.6

1.5

0.41

0.38

ug/l

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.72

1.23

1.3

1.8

0.56

0.75

u/field

0.37

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

111

513

1.22

1.21

1.3

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

858

4526

1.07

1.20

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

109

1.50

1.19

1.7

1.4

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.67

1.11

1.1

1.2

11.44

28.20

u/ml

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.57

1.10

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

121

1.45

1.08

1.1

1.0

0.03

0.26

u/ml

1.39

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.20

1.06

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

137

1.40

1.02

1.3

1.5

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.57

1.01

1.0

0.22

4.84

u/ml

1.36

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

119

1.42

0.98

1.1

0.19

0.55

u/ml

0.83

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.26

0.93

2.0

1.2

2.00

4.17

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1001

5953

0.95

0.91

1.4

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.96

0.90

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

161

1.33

0.88

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1005

5967

0.95

0.87

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1000

5938

0.95

0.87

1.4

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

338

1.22

0.85

5.9

6.7

1178.25

9963.30

u/ml

0.52

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1005

5962

0.95

0.85

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1079

6374

0.95

0.79

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

121

592

1.16

0.79

2.8

3.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.98

0.77

6.4

1.5

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

2.17

0.76

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

224

0.76

1.8

1.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1072

5793

1.05

0.75

1.6

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

131

1.34

0.75

1.1

0.02

7.49

u/ml

1.34

105

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.40

0.72

1.1

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.43

0.71

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.72

0.70

1.0

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.40

0.69

1.1

4.25

10.46

u/ml

1.77

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.37

0.68

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.88

0.68

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

437

0.84

0.68

3.3

3.5

7.11

8.65

mg/l

1.34

358

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

278

1699

0.92

0.64

1.6

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.38

0.63

5.8

3.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.55

0.57

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

134

1.26

0.54

1.1

0.03

4.28

u/ml

2.51

102

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2088

11519

1.03

0.52

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

585

0.89

0.50

1.4

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.57

0.42

1.2

1.1

—

(3022670) pH of Venous cord blood

1.41

0.40

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.34

0.39

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.36

0.34

1.0

—

(3006598) pH of Arterial cord blood

100

0.79

0.31

1.2

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.32

0.31

1.1

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

995

5488

1.03

0.31

1.8

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

399

0.91

0.30

2.9

124.92

120.61

au/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.22

0.29

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.69

0.27

1.2

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

108

1.15

0.20

2.2

2.7

—

(46235168) Fasting glucose [Moles/volume] in Blood

112

0.86

0.19

1.4

1.1

6.80

5.47

mmol/l

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.85

0.16

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.16

0.16

1.0

1.1

—

(3008607) Semen analysis panel

102

1.11

0.11

1.2

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.18

0.11

1.1

8.92

8.38

mmol/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.15

0.10

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1348

7666

0.99

0.09

1.5

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.15

0.09

1.2

332.80

298.59

umol/24h

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

528

1.02

0.03

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

348

0.99

0.00

1.9

2.1

9.87

10.36

mg/l

0.27

288

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

313

1766

1.00

0.00

1.5

1.6

7.70

7.34

mmol/l

2.44

306

1692

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

376

2126

1.00

0.00

1.7

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.97

0.00

1.2

1.1

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.88

-0.00

5.7

6.2

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.00

-0.00

1.4

1.3

1.46

1.60

mg/l

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: HYPOTHYROIDISM – Hypothyroidism (congenital or acquired)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hypothyroidism (congenital or acquired)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints